CPJE Practice Test

California Practice Standards and Jurisprudence Examination for Pharmacists (CPJE)

CPJE overview

  • 200 practice questions
  • 32 flashcards
  • 2 study guide topics
  • 38 key terms

What you'll study

  • California pharmacy law and jurisprudence50%
  • Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)50%

The California Practice Standards and Jurisprudence Examination for Pharmacists, known as the CPJE, is a California-specific examination associated with pharmacist licensure in the state. It is intended for candidates who are pursuing pharmacist licensure in California and who need to demonstrate knowledge of California pharmacy law and of practice standards expected of pharmacists in the state. The exam is organized around two content areas: California pharmacy law and jurisprudence, and pharmacist practice standards covering patient care, dispensing, compounding, and medication safety. Preparation should be built around California-specific law and regulation rather than general pharmacology alone, since the jurisprudence portion rewards precise knowledge of state requirements. Candidates should consult the California State Board of Pharmacy for authoritative information on test dates, application procedures, licensing requirements, and official publications such as the lawbook and laws and regulations materials. Because rules and procedures change, always confirm details directly with the Board rather than relying on secondhand summaries. This page is an independent study resource and is not affiliated with or endorsed by the California State Board of Pharmacy; it is intended to help candidates organize their study and understand what the examination emphasizes.

Common mistakes

Applying the federal DEA schedule or federal refill rules to a California prescription instead of checking the California-specific requirement (for example, treating a Schedule II prescription as valid for 90 days because federal law allows it, or accepting a Schedule II refill).

Candidates study federal controlled-substance law in depth and assume it overrides state law, when California imposes stricter or different requirements (expiration, refill limits, transmission rules) that the exam tests directly.

What to do instead

For every controlled-substance item, ask two separate questions: what does federal law require, and what does California require? Memorize the California limits (e.g., Schedule II no refills, six-month expiration for most controlled substances, Schedule III–V refill limits) as distinct facts and drill them until they are automatic.

Dispensing or counseling without documenting the required patient consultation or without recognizing when a prescription may be filled without the prescriber's oral confirmation (e.g., treating every emergency oral Schedule II as unfillable, or filling one without the required follow-up written prescription).

Candidates conflate the emergency oral prescription exception with routine practice and do not learn the timing and documentation conditions that make the exception lawful.

What to do instead

Build a one-page decision tree for emergency oral controlled-substance prescriptions: who may call, what must be recorded, and the deadline for the follow-up written prescription. Practice with short scenarios until the conditions are recalled without hesitation.

Failing to identify which tasks may be delegated to a pharmacy technician or intern versus retained by the pharmacist, and answering based on what happens in their own workplace rather than the legal scope.

Workflow habits from real practice vary by site, and candidates generalize from their own experience instead of the statutory delegation limits.

What to do instead

Make a two-column table (pharmacist-only vs. delegable with supervision) and populate it from the statutes and board guidance, not from memory of a workplace. Test yourself by classifying 20 tasks in under five minutes.

Missing recordkeeping and retention requirements - assuming all prescription records are kept for the same period, or that a record can be discarded once the prescription is filled.

Retention periods differ by record type and candidates memorize a single number that they apply to everything.

What to do instead

Create a retention table keyed by record type (prescription files, controlled-substance records, compounding logs, counseling documentation) with the exact period for each. Review it weekly and quiz yourself by record type rather than by number.

Answering drug-therapy questions from drug-name familiarity rather than working through the patient-specific data given (renal function, age, weight, interacting drugs) before selecting an option.

Under time pressure, candidates pattern-match on the drug name and skip the calculation or the contraindication check embedded in the stem.

What to do instead

Force a fixed routine for every clinical item: list the relevant patient variables, then the drug variables, then eliminate. Do timed sets where you must write the one-line reason each distractor is wrong before choosing.

Choosing a monitoring parameter that is convenient rather than the one that actually detects the adverse effect of the drug in question (e.g., monitoring the wrong lab for a known toxicity, or omitting baseline values).

Candidates remember that a drug 'needs monitoring' but not which parameter, so they pick a plausible lab that is not the correct one.

What to do instead

Build drug-to-monitoring-parameter flashcards with baseline and follow-up timing, and include the toxicity each parameter detects. Review by toxicity first, then recall the drug and the test.

Calculating doses or compounding quantities without verifying units and without checking that the final concentration or quantity is clinically plausible before selecting an answer.

Unit mismatches (mg vs. mcg, percent vs. mg/mL) and multi-step conversions cause silent arithmetic errors, and candidates do not sanity-check the result.

What to do instead

Use dimensional analysis on every calculation and write units at each step. After computing, ask whether the answer is plausible for the patient and product; if not, recompute before answering. Practice with compounding concentration problems weekly.

Ignoring the sterile versus nonsterile compounding distinction and applying the wrong beyond-use date, environment, or garbing requirement to a preparation scenario.

Candidates treat all compounding as one category and memorize a single BUD instead of the risk-level framework and the conditions that change the date.

What to do instead

Map each preparation to its risk category first, then apply the corresponding BUD, environment, and personnel requirements. Practice by classifying 15 short scenarios by risk level before answering the BUD question.

Selecting a response to a medication error or look-alike/sound-alike hazard that addresses the individual event but not the system fix (e.g., counseling the person involved instead of changing storage, labeling, or workflow).

Candidates default to the interpersonal action because it feels like a complete answer, and they do not distinguish correction from prevention.

What to do instead

For every safety item, ask whether the option prevents recurrence at the system level. Eliminate options that only punish, remind, or re-educate a single person, and prefer options that change labeling, separation, verification steps, or technology.

Answering patient-counseling and self-care items with the most comprehensive information rather than the information appropriate to the situation, and skipping referral red flags.

Candidates equate 'more counseling' with 'better counseling' and overlook that the question is testing triage and appropriateness.

What to do instead

For each scenario, first decide whether the patient should be referred or managed with self-care, then select the counseling content matched to that decision. Memorize a short list of referral red flags and check the stem against it before reading the options.

Exam requirements can change. Confirm current details with the exam provider.

CPJE practice

200 questions. Each one lists the choices, the correct answer, and an explanation. With JavaScript, this list opens one question at a time. The checker at the top of this page saves progress in this browser when it is available.

  1. Question 1California pharmacy law and jurisprudence

    Under California law, a pharmacist may refill a prescription for a Schedule III controlled substance how many times before a new prescription is required?

    1. No refills are permitted for Schedule III drugs
    2. Five refills within six months of the issue date
    3. Up to five refills within six months of the issue date Correct answer.
    4. As many refills as the prescriber authorizes within one year

    Explanation

    California follows federal rules limiting Schedule III and IV prescriptions to a maximum of five refills, and no refill may be dispensed more than six months after the date the prescription was issued. Schedule II prescriptions cannot be refilled at all.

  2. Question 2California pharmacy law and jurisprudence

    A prescriber telephones a pharmacy to authorize a Schedule II prescription for a patient. Under California law, which statement best describes the pharmacist's authority?

    1. The pharmacist may dispense on the oral order and must obtain a written prescription within seven days
    2. The pharmacist may never accept an oral order for a Schedule II drug under any circumstance
    3. The pharmacist may dispense on the oral order only in a bona fide emergency, with a written prescription delivered within seven days Correct answer.
    4. The pharmacist may dispense on the oral order if the prescriber is a specialist in the treated condition

    Explanation

    California permits an oral Schedule II order only in a bona fide emergency, and the prescriber must furnish a written prescription within seven days. Routine telephone orders for Schedule II drugs are not permitted.

  3. Question 3California pharmacy law and jurisprudence

    Which body within the California Department of Consumer Affairs is responsible for licensing pharmacists and enforcing the Pharmacy Law?

    1. The Board of Pharmacy Correct answer.
    2. The Office of the Attorney General
    3. The Medical Board of California
    4. The Department of Public Health

    Explanation

    The California State Board of Pharmacy, part of the Department of Consumer Affairs, licenses pharmacists and pharmacies and administers the Pharmacy Law. The other entities have different statutory mandates.

  4. Question 4California pharmacy law and jurisprudence

    A pharmacy technician may perform which of the following tasks in a California pharmacy without direct pharmacist supervision at the moment of the act?

    1. Performing the final check of a filled prescription
    2. Making the decision to substitute a generic drug
    3. Typing prescription data into the pharmacy system Correct answer.
    4. Counseling a patient on a new prescription

    Explanation

    California allows certified pharmacy technicians to perform certain tasks such as entering prescription data, but counseling, final verification, and therapeutic decisions remain pharmacist functions. Final check of a prescription is a pharmacist duty.

  5. Question 5California pharmacy law and jurisprudence

    A pharmacist receives a prescription that appears to be forged. Under California law, the pharmacist should do which of the following?

    1. Call the patient to confirm the prescription is genuine
    2. Dispense only half the quantity to limit harm
    3. Dispense the prescription and notify the Board later
    4. Refuse to dispense and report the matter to the appropriate authority Correct answer.

    Explanation

    A pharmacist who has reason to believe a prescription is forged should decline to fill it and report the matter to law enforcement or the Board of Pharmacy. Dispensing a suspected forgery exposes the pharmacist to liability and undermines the reporting duty.

  6. Question 6California pharmacy law and jurisprudence

    Under California law, a prescription for a Schedule II controlled substance is generally valid for how long after the date of issue?

    1. One year
    2. Six months
    3. Ninety days
    4. Thirty days Correct answer.

    Explanation

    California law generally limits the validity of a Schedule II prescription to 30 days from the date written, unless a specific exception applies. Schedule III–V prescriptions have a six-month limit.

  7. Question 7California pharmacy law and jurisprudence

    A patient asks a California pharmacist to dispense a lower-cost therapeutically equivalent generic drug. Which statement reflects California law on generic substitution?

    1. Substitution is permitted unless the prescriber or patient objects, and the patient must be informed Correct answer.
    2. Substitution is prohibited for any drug with a narrow therapeutic index
    3. Substitution requires Board of Pharmacy approval for each drug
    4. Substitution requires the prescriber's prior written consent in all cases

    Explanation

    California permits pharmacists to substitute a therapeutically equivalent generic unless the prescriber indicates otherwise or the patient objects, and the patient must be notified of the substitution. The pharmacist retains responsibility for the substitution.

  8. Question 8California pharmacy law and jurisprudence

    Which of the following is required on the label of a prescription dispensed in California?

    1. The manufacturer's lot number only
    2. The wholesale acquisition cost of the drug
    3. The pharmacist's home telephone number
    4. The name and address of the prescriber and the patient's name Correct answer.

    Explanation

    California requires prescription labels to include specified information such as the patient's name, the prescriber's name, and directions for use, along with the pharmacy's identifying information. Cost and pharmacist personal contact information are not required label elements.

  9. Question 9California pharmacy law and jurisprudence

    A California pharmacy receives a prescription for a drug that is a Schedule II controlled substance but the prescriber writes it on a form that lacks the required security features. What is the pharmacist's best course of action?

    1. Refuse to fill and contact the prescriber for a compliant prescription Correct answer.
    2. Fill it and annotate the file with the deficiency
    3. Report the prescriber to law enforcement and dispense anyway
    4. Dispense the drug because the drug itself is legitimate

    Explanation

    California requires Schedule II prescriptions to be written on forms meeting specified security requirements. A pharmacist should not fill a noncompliant prescription and should obtain a compliant one from the prescriber.

  10. Question 10California pharmacy law and jurisprudence

    Under California law, a pharmacist may dispense a prescription drug without a prescription in which of the following situations?

    1. When the drug is a Schedule V product
    2. When the patient requests a refill of an expired prescription
    3. When the patient is traveling and forgot the medication
    4. When the pharmacist is providing emergency contraception under the appropriate protocol Correct answer.

    Explanation

    California specifically authorizes pharmacists to furnish certain products, including emergency contraception, under defined protocols without a prior prescription. Routine dispensing of other prescription drugs still requires a valid prescription.

  11. Question 11California pharmacy law and jurisprudence

    A pharmacy's records for Schedule II controlled substances must be maintained for what minimum period under California law?

    1. Five years
    2. Three years
    3. Two years Correct answer.
    4. One year

    Explanation

    California requires controlled substance records to be kept for at least two years and made available for inspection. This aligns with the recordkeeping requirements for controlled substances.

  12. Question 12California pharmacy law and jurisprudence

    A pharmacist discovers that a prescription was dispensed with an incorrect drug. Which action best reflects California's reporting expectations?

    1. Document the error internally and take no further action
    2. Report the error to the Board of Pharmacy as required and notify the patient and prescriber Correct answer.
    3. Wait for the patient to complain before acting
    4. Report only if the patient suffers harm

    Explanation

    California requires reporting of specified medication errors to the Board and appropriate notification of the patient and prescriber. Internal documentation alone does not satisfy reporting obligations.

  13. Question 13California pharmacy law and jurisprudence

    Which of the following best describes the California requirement for pharmacist counseling of patients receiving a new prescription?

    1. Counseling may be provided only in writing
    2. Counseling is required only for controlled substances
    3. Counseling must be offered and provided in a manner the patient can understand Correct answer.
    4. Counseling is optional and may be delegated to a technician

    Explanation

    California requires that patients be offered and given counseling on new prescriptions in a manner they can understand, and the pharmacist is responsible for this function. Counseling may be provided orally, in writing, or by other means that ensure understanding.

  14. Question 14California pharmacy law and jurisprudence

    A pharmacy wishes to operate as a licensed California pharmacy. Which statement is correct regarding the requirement for a pharmacist-in-charge?

    1. A pharmacist-in-charge is optional if the owner is a pharmacist
    2. A pharmacist-in-charge is required only for pharmacies dispensing controlled substances
    3. Only hospitals must designate a pharmacist-in-charge
    4. Every licensed pharmacy must have a pharmacist-in-charge Correct answer.

    Explanation

    California requires every licensed pharmacy to designate a pharmacist-in-charge who is responsible for compliance with the Pharmacy Law. The requirement is not limited by the type of drugs dispensed or ownership.

  15. Question 15California pharmacy law and jurisprudence

    Under California law, how must a pharmacy handle a prescription for a controlled substance when the pharmacist suspects the patient is obtaining the drug from multiple prescribers for abuse?

    1. Dispense the drug and document the concern
    2. Dispense a reduced quantity without informing the patient
    3. Refuse to dispense and take appropriate action such as contacting the prescriber or reporting Correct answer.
    4. Refer the patient to another pharmacy without documentation

    Explanation

    A pharmacist with a reasonable belief of abuse or diversion should decline to dispense and take appropriate steps, such as contacting the prescriber or reporting the matter. California law supports the pharmacist's corresponding responsibility to ensure legitimate medical purpose.

  16. Question 16California pharmacy law and jurisprudence

    Which of the following prescriptions must be retained by the pharmacy as part of its prescription records in California?

    1. Only prescriptions for compounded products
    2. Only prescriptions for controlled substances
    3. Only prescriptions the patient requests be kept
    4. All prescriptions dispensed by the pharmacy Correct answer.

    Explanation

    California requires pharmacies to maintain records of all prescriptions dispensed, not just controlled substances. These records must be available for inspection for the required retention period.

  17. Question 17California pharmacy law and jurisprudence

    A California pharmacy employs a pharmacist who is also licensed in another state. Which statement is correct about practicing pharmacy in California?

    1. The pharmacist may practice if supervised by a California-licensed pharmacist
    2. The pharmacist must hold a current California pharmacist license Correct answer.
    3. The pharmacist may practice for up to one year on the out-of-state license
    4. A license from any state permits practice in California

    Explanation

    California requires a current California pharmacist license to practice pharmacy in the state. Out-of-state licensure does not authorize practice in California, and no grace period exists.

  18. Question 18California pharmacy law and jurisprudence

    Under California law, a pharmacy must report a change of pharmacist-in-charge to the Board of Pharmacy within what timeframe?

    1. Only at the time of license renewal
    2. Within 30 days of the change Correct answer.
    3. Within 60 days of the change
    4. Within 10 days of the change

    Explanation

    California requires notification to the Board of Pharmacy of a change in the pharmacist-in-charge within 30 days. Timely notification keeps the pharmacy's licensure records accurate.

  19. Question 19California pharmacy law and jurisprudence

    A patient presents a prescription for a Schedule IV controlled substance that was written 45 days ago. Under California law, may the pharmacist dispense it?

    1. No, because Schedule IV prescriptions expire after 30 days
    2. No, because Schedule IV prescriptions expire after 14 days
    3. Yes, but only with prescriber reauthorization
    4. Yes, because Schedule IV prescriptions remain valid for up to six months Correct answer.

    Explanation

    California permits Schedule III–V prescriptions to be filled within six months of the date written, subject to the refill limits. A 45-day-old Schedule IV prescription is therefore still valid.

  20. Question 20California pharmacy law and jurisprudence

    Which of the following is a function of the California State Board of Pharmacy?

    1. Operating public hospitals
    2. Setting physician reimbursement rates
    3. Certifying medical devices for sale
    4. Issuing pharmacy licenses and investigating complaints against licensees Correct answer.

    Explanation

    The Board of Pharmacy licenses pharmacies and pharmacists and investigates complaints and disciplinary matters involving licensees. Reimbursement, hospital operation, and device certification fall to other agencies.

  21. Question 21California pharmacy law and jurisprudence

    A pharmacist is asked to dispense a drug that is not approved by the FDA but is available in another country. Which statement best reflects California law?

    1. Dispensing unapproved foreign drugs generally violates California and federal law Correct answer.
    2. The pharmacist may dispense it if the drug is cheaper than the U.S. version
    3. The pharmacist may dispense it if the prescriber writes the prescription
    4. The pharmacist may dispense it if the patient signs a waiver

    Explanation

    California and federal law generally prohibit dispensing unapproved foreign drugs, with narrow exceptions. A patient waiver or prescriber order does not create a general authority to dispense unapproved products.

  22. Question 22California pharmacy law and jurisprudence

    Under California law, which of the following best describes the requirement for a pharmacist to provide a prescription drug to a patient who cannot understand English?

    1. The pharmacist may delegate counseling to any bilingual employee
    2. The pharmacist may refuse to dispense
    3. The pharmacist must provide counseling in a manner the patient can understand, using interpretation if needed Correct answer.
    4. The pharmacist must provide only written English instructions

    Explanation

    California requires counseling in a manner the patient can understand, which may require interpretation or translated materials. Counseling remains the pharmacist's responsibility.

  23. Question 23California pharmacy law and jurisprudence

    Which of the following is required for a pharmacy to dispense a controlled substance via an automated dispensing system in California?

    1. The system must be approved and the pharmacy must maintain required security and records Correct answer.
    2. No special requirements apply to automated systems
    3. Only a physician may access the system
    4. The system may operate without pharmacist oversight

    Explanation

    California requires automated dispensing systems to meet approval, security, and recordkeeping requirements, and pharmacist oversight is maintained. The system does not eliminate the pharmacy's legal responsibilities.

  24. Question 24California pharmacy law and jurisprudence

    A California pharmacist receives a prescription for a drug that is on the state's list of scheduled substances but is prescribed for a legitimate medical purpose. Which statement is correct?

    1. The pharmacist may dispense if the prescription meets all legal requirements for that schedule Correct answer.
    2. The pharmacist may dispense only with Board approval
    3. The pharmacist may dispense only if the patient is terminally ill
    4. The pharmacist may never dispense scheduled substances

    Explanation

    Scheduled substances may be dispensed when the prescription satisfies the legal requirements for that schedule, including valid prescriber, patient, and form requirements. A legitimate medical purpose supports dispensing within those rules.

  25. Question 25California pharmacy law and jurisprudence

    Which of the following best describes California's requirement for a pharmacy to maintain a clean and sanitary environment?

    1. Sanitation is enforced only after a patient complaint
    2. The pharmacy must be maintained in a clean and sanitary condition as a condition of licensure Correct answer.
    3. Sanitation is required only in compounding areas
    4. Sanitation is optional if the pharmacy is small

    Explanation

    California requires pharmacies to be maintained in a clean and sanitary condition as part of licensure compliance. Sanitation obligations apply throughout the pharmacy, not only in compounding areas.

  26. Question 26California pharmacy law and jurisprudence

    Under California law, what is the maximum number of refills permitted for a prescription for a Schedule III controlled substance?

    1. Six
    2. Two
    3. Five Correct answer.
    4. Three

    Explanation

    California Business and Professions Code section 4170 limits Schedule III and IV prescriptions to a maximum of five refills within six months of the date written. Schedule II prescriptions cannot be refilled.

  27. Question 27California pharmacy law and jurisprudence

    A California pharmacy technician may perform which of the following tasks without direct pharmacist supervision?

    1. Answering a question about drug interactions
    2. Counseling a patient on a new prescription
    3. Performing the final check on a filled prescription
    4. Stocking shelves with nonprescription items Correct answer.

    Explanation

    Pharmacy technicians may perform clerical and stock-related tasks, but clinical functions such as counseling, final verification, and therapeutic consultation require a pharmacist. Stocking nonprescription items does not involve professional judgment.

  28. Question 28California pharmacy law and jurisprudence

    Which of the following is required for a pharmacist to administer a vaccine to a patient under California law?

    1. A separate pharmacist-administering certification from the Board
    2. Completion of an ACPE-accredited immunization training program Correct answer.
    3. Annual re-licensure as an immunizing pharmacist
    4. A written order from the patient's primary care physician

    Explanation

    California law allows pharmacists to administer vaccines if they have completed an ACPE-accredited immunization training program and meet other requirements. No separate certification or physician order is required for most vaccines.

  29. Question 29California pharmacy law and jurisprudence

    Under California law, a pharmacy must notify the Board of Pharmacy of a change in the pharmacy's address within what timeframe?

    1. 60 days
    2. 30 days Correct answer.
    3. 10 days
    4. 45 days

    Explanation

    California Business and Professions Code section 4081 requires notification to the Board within 30 days of a change in the pharmacy's address or other specified changes. This allows the Board to update its records and inspect the new location if needed.

  30. Question 30California pharmacy law and jurisprudence

    Which of the following best describes the California requirement for a pharmacist to report a suspected adverse drug reaction to the Board of Pharmacy?

    1. Reporting is required only for reactions resulting in hospitalization
    2. Reporting is mandatory for all adverse reactions
    3. Reporting is not required; pharmacists may report to the manufacturer or FDA Correct answer.
    4. Reporting is required only for controlled substances

    Explanation

    California law does not require pharmacists to report adverse drug reactions to the Board of Pharmacy. Pharmacists may voluntarily report to the FDA MedWatch program or the manufacturer.

  31. Question 31California pharmacy law and jurisprudence

    A California pharmacy receives a verbal prescription for a Schedule II controlled substance in a genuine emergency. Which action is required?

    1. The pharmacist must refuse the verbal order
    2. The prescriber must deliver a written prescription within 7 days Correct answer.
    3. The prescriber must confirm the order by fax within 24 hours
    4. The pharmacist must obtain a written prescription within 30 days

    Explanation

    Under California law, in an emergency situation, a pharmacist may dispense a Schedule II controlled substance based on a verbal order, but the prescriber must provide a written prescription within 7 days. If not received, the pharmacist must notify the Board.

  32. Question 32California pharmacy law and jurisprudence

    Which of the following is a requirement for a pharmacy to obtain a sterile compounding license in California?

    1. A separate license for each sterile compounding pharmacist
    2. A written agreement with a hospital
    3. Compliance with USP <797> standards Correct answer.
    4. Annual inspection by the FDA

    Explanation

    California requires pharmacies engaged in sterile compounding to comply with USP <797> standards, among other requirements. A separate license for each pharmacist or an FDA inspection is not required.

  33. Question 33California pharmacy law and jurisprudence

    Under California law, what is the minimum age for a person to purchase a nonprescription pseudoephedrine product?

    1. 18 years Correct answer.
    2. There is no age restriction
    3. 16 years
    4. 21 years

    Explanation

    California law restricts the sale of nonprescription pseudoephedrine products to persons 18 years of age or older and requires a government-issued photo ID. This is part of the state's efforts to curb methamphetamine production.

  34. Question 34California pharmacy law and jurisprudence

    A California pharmacist is asked to dispense a prescription that was transmitted by electronic data interchange (EDI) for a Schedule II controlled substance. Which statement is correct?

    1. EDI prescriptions for Schedule II are allowed only for hospice patients
    2. EDI prescriptions for Schedule II are permitted if they meet DEA and state requirements Correct answer.
    3. EDI prescriptions for Schedule II are prohibited in California
    4. EDI prescriptions for Schedule II require a follow-up written prescription

    Explanation

    California allows electronic prescribing of Schedule II controlled substances when the system complies with DEA and state requirements, including identity proofing and audit trails. No follow-up written prescription is required.

  35. Question 35California pharmacy law and jurisprudence

    Which of the following is required on a prescription container label for a controlled substance in California?

    1. A red 'C' to indicate controlled status
    2. The prescriber's DEA number
    3. The pharmacy's DEA number Correct answer.
    4. The patient's diagnosis

    Explanation

    California requires the pharmacy's DEA number on the label of a controlled substance prescription. The prescriber's DEA number and the patient's diagnosis are not required on the label.

  36. Question 36California pharmacy law and jurisprudence

    A California pharmacy wants to provide prescription drugs to patients through a mail-order service. Which of the following is required?

    1. Compliance with the same labeling and counseling requirements as a walk-in pharmacy Correct answer.
    2. A separate mail-order license from the Board
    3. An on-site physician for consultations
    4. A surety bond

    Explanation

    Mail-order pharmacies in California must follow the same laws regarding labeling, counseling, and recordkeeping as any other pharmacy. No separate mail-order license or on-site physician is required.

  37. Question 37California pharmacy law and jurisprudence

    Under California law, when must a pharmacy report the theft of a controlled substance to the Board of Pharmacy?

    1. Within 24 hours of discovery Correct answer.
    2. Only if the theft exceeds $1,000 in value
    3. Within 7 days of discovery
    4. Within 30 days of discovery

    Explanation

    California requires pharmacies to report the theft or loss of controlled substances to the Board of Pharmacy within 24 hours of discovery. A DEA Form 106 must also be filed.

  38. Question 38California pharmacy law and jurisprudence

    A patient requests a prescription transfer from Pharmacy A to Pharmacy B in California. Which statement is correct?

    1. Only the original pharmacy may initiate the transfer
    2. The transfer may be communicated orally between pharmacists Correct answer.
    3. The patient must provide written consent for the transfer
    4. The transferring pharmacy must cancel the original prescription

    Explanation

    California allows prescription transfers between pharmacies to be communicated orally between pharmacists, provided all required information is exchanged and documented. Written patient consent is not required.

  39. Question 39California pharmacy law and jurisprudence

    Which of the following is a requirement for a California pharmacy to participate in the CURES database?

    1. Reporting of dispensed controlled substances within 7 days Correct answer.
    2. Consultation of CURES before dispensing any controlled substance
    3. Annual audit by the Board
    4. Registration of all pharmacy technicians

    Explanation

    California requires dispensers to report controlled substance dispensing information to CURES within 7 days of dispensing. Pharmacists must consult CURES before dispensing Schedule II-IV drugs under specified circumstances.

  40. Question 40California pharmacy law and jurisprudence

    A California pharmacist receives a prescription for a Schedule II controlled substance that lacks the prescriber's DEA number. What is the appropriate action?

    1. Substitute a Schedule III medication
    2. Dispense the prescription and obtain the DEA number later
    3. Refuse to dispense until the DEA number is provided Correct answer.
    4. Report the prescriber to the Board

    Explanation

    A valid prescription for a controlled substance must include the prescriber's DEA number. The pharmacist should not dispense until the missing information is obtained.

  41. Question 41California pharmacy law and jurisprudence

    Under California law, which of the following is required for a pharmacist to prescribe emergency contraception?

    1. A collaborative practice agreement
    2. A separate prescribing license
    3. Completion of a Board-approved training program Correct answer.
    4. A physician's written protocol

    Explanation

    California allows pharmacists to furnish emergency contraception after completing a Board-approved training program. A collaborative practice agreement or physician protocol is not required for this specific authority.

  42. Question 42California pharmacy law and jurisprudence

    A California pharmacy is closing permanently. What is the required action regarding controlled substances in its inventory?

    1. Return all controlled substances to the manufacturer
    2. Notify the Board and DEA and arrange for proper disposal or transfer Correct answer.
    3. Destroy all controlled substances without documentation
    4. Transfer to another pharmacy without notifying the Board

    Explanation

    When a pharmacy closes, it must notify the Board of Pharmacy and the DEA and arrange for the transfer or destruction of controlled substances with proper documentation. Unauthorized transfer or undocumented destruction is illegal.

  43. Question 43California pharmacy law and jurisprudence

    Which of the following best describes the California requirement for a pharmacy to provide a patient with a written prescription receipt?

    1. A receipt is required only for controlled substances
    2. A receipt is required only if the patient requests one
    3. A receipt is required for Medi-Cal prescriptions Correct answer.
    4. A receipt is required for all prescriptions

    Explanation

    California law requires pharmacies to provide a receipt for Medi-Cal prescriptions, detailing the drug and the amount paid. Receipts are not universally required for all prescriptions.

  44. Question 44California pharmacy law and jurisprudence

    A pharmacist in California is asked to dispense a drug that is the subject of a voluntary recall. What is the appropriate action?

    1. Dispense with a warning to the patient
    2. Return the drug to the manufacturer and document the recall Correct answer.
    3. Dispense the drug if the patient insists
    4. Continue dispensing until the Board issues an order

    Explanation

    Pharmacists should remove recalled drugs from inventory and return them according to the recall instructions, documenting the action. Dispensing a recalled drug could harm patients and violate the law.

  45. Question 45California pharmacy law and jurisprudence

    Under California law, what is the maximum time a pharmacist may leave a pharmacy without a pharmacist on duty?

    1. Up to 1 hour
    2. Up to 2 hours if a technician is present
    3. No pharmacist may be absent from the pharmacy while it is open Correct answer.
    4. Up to 30 minutes

    Explanation

    California law requires a pharmacist to be on duty at all times when the pharmacy is open. A pharmacy cannot operate without a pharmacist present.

  46. Question 46California pharmacy law and jurisprudence

    A California pharmacist is asked to dispense a prescription for a drug that is not FDA-approved but is approved in Canada. Which statement is correct?

    1. The pharmacist may dispense it if it is listed in the Orange Book
    2. The pharmacist may not dispense it without prior Board authorization Correct answer.
    3. The pharmacist may dispense it if the patient signs a waiver
    4. The pharmacist may dispense it only with a physician's written order

    Explanation

    California law generally prohibits dispensing unapproved drugs unless specific exceptions apply. A pharmacist should not dispense a non-FDA-approved drug without proper authorization, such as Board approval for a specific patient.

  47. Question 47California pharmacy law and jurisprudence

    Which of the following is required for a California pharmacy to maintain a drug pedigree for prescription drugs?

    1. A pedigree is required only for controlled substances
    2. A pedigree is required for all prescription drugs
    3. A pedigree is required only for drugs purchased from a wholesaler
    4. A pedigree is required for drugs that are at risk of diversion Correct answer.

    Explanation

    California's pedigree law applies to prescription drugs that are at risk of diversion or counterfeiting, as designated by the Board. Not all prescription drugs require a pedigree.

  48. Question 48California pharmacy law and jurisprudence

    A California pharmacy uses an automated dispensing system to store and dispense controlled substances. Which of the following is required?

    1. The system must be approved by the DEA
    2. The system must have a mechanism to track and audit access Correct answer.
    3. The system must be physically separated from other drugs
    4. The system must be restocked only by a pharmacist

    Explanation

    California requires automated dispensing systems to have security and audit mechanisms to track access and dispensing of controlled substances. DEA approval of the system itself is not required.

  49. Question 49California pharmacy law and jurisprudence

    Under California law, which of the following is true regarding a pharmacist's participation in a syringe exchange program?

    1. Pharmacists must report participants to law enforcement
    2. Pharmacists may furnish syringes without a prescription to participants Correct answer.
    3. Pharmacists may not participate without a physician's order
    4. Pharmacists may participate only if the pharmacy is licensed as a syringe exchange

    Explanation

    California law allows pharmacists to provide syringes to participants of authorized syringe exchange programs without a prescription. This is part of harm reduction efforts.

  50. Question 50California pharmacy law and jurisprudence

    A California pharmacist is asked to dispense a prescription for a controlled substance that was written by a prescriber in another state. Which of the following is required?

    1. The pharmacist must verify the prescription with the prescriber Correct answer.
    2. The prescription must be filled only if the patient is a California resident
    3. The prescriber must be licensed in California
    4. The prescriber must have a California DEA registration

    Explanation

    California allows pharmacists to fill valid out-of-state prescriptions for controlled substances if the prescriber is properly licensed in their state and the prescription meets California requirements. The pharmacist must verify the prescription's authenticity, often by contacting the prescriber.

  51. Question 51California pharmacy law and jurisprudence

    Under California law, a pharmacist may refuse to fill a prescription for a controlled substance if the pharmacist has a corresponding responsibility and believes the prescription is for a legitimate medical purpose. Which of the following best describes the pharmacist's corresponding responsibility?

    1. The pharmacist must report the prescriber to the Medical Board before refusing.
    2. The pharmacist must obtain a patient signature before dispensing.
    3. The pharmacist must fill all valid prescriptions regardless of concerns.
    4. The pharmacist must verify the prescription's legitimacy and may refuse to fill if there is a red flag. Correct answer.

    Explanation

    California law recognizes the pharmacist's corresponding responsibility to ensure that controlled substances are dispensed only for a legitimate medical purpose. This duty allows a pharmacist to refuse to fill a prescription when red flags indicate potential abuse or diversion. The pharmacist is not required to fill every prescription and may take steps to resolve concerns.

  52. Question 52California pharmacy law and jurisprudence

    Which of the following is required for a California pharmacy to store and handle dangerous drugs?

    1. A separate locked refrigerator for all dangerous drugs.
    2. A monthly inventory audit by the pharmacist-in-charge.
    3. A security camera monitoring all drug storage areas.
    4. A designated area with limited access to authorized personnel. Correct answer.

    Explanation

    California law requires that dangerous drugs be stored in a designated area with access limited to authorized personnel. This helps prevent diversion and ensure drug integrity. Other security measures may be used but are not specifically mandated for all dangerous drugs.

  53. Question 53California pharmacy law and jurisprudence

    A California pharmacy technician is preparing a sterile compounded preparation. Which of the following is required regarding supervision?

    1. The technician may compound without supervision if certified.
    2. The technician must be supervised by a pharmacist at all times during compounding. Correct answer.
    3. The technician may compound only after obtaining a sterile compounding license.
    4. The technician must have a second technician verify the preparation.

    Explanation

    California law requires that pharmacy technicians performing sterile compounding be supervised by a pharmacist. Direct supervision ensures safety and compliance with standards. Certification alone does not permit unsupervised compounding.

  54. Question 54California pharmacy law and jurisprudence

    Under California law, which of the following is true regarding the sale of hypodermic needles and syringes to a person 18 years of age or older?

    1. The purchaser must provide identification and sign a record.
    2. The sale is permitted without a prescription for personal use. Correct answer.
    3. The sale is prohibited except for medical use.
    4. A prescription is required for purchase.

    Explanation

    California allows the sale of hypodermic needles and syringes without a prescription to persons 18 or older for personal use. This is part of harm reduction efforts. Pharmacies may sell them without requiring a prescription.

  55. Question 55California pharmacy law and jurisprudence

    A California pharmacist is asked to dispense a prescription for a Schedule III controlled substance. The prescription was transmitted orally by a prescriber. Which of the following is correct regarding the pharmacist's ability to dispense?

    1. The pharmacist may dispense the oral prescription and must reduce it to writing. Correct answer.
    2. The pharmacist may not dispense an oral prescription for a Schedule III drug.
    3. The pharmacist may dispense only if the prescriber provides a written follow-up within 7 days.
    4. The pharmacist may dispense only if the prescriber is a specialist.

    Explanation

    California law permits oral prescriptions for Schedule III controlled substances. The pharmacist must reduce the oral prescription to writing and retain it as a record. A written follow-up is not required within a specific timeframe for Schedule III.

  56. Question 56California pharmacy law and jurisprudence

    Which of the following is a requirement for a California pharmacy to maintain a license to compound sterile preparations?

    1. The pharmacy must use only automated compounding devices.
    2. The pharmacy must obtain a sterile compounding license from the Board of Pharmacy. Correct answer.
    3. The pharmacy must employ a full-time microbiologist.
    4. The pharmacy must have a separate room with positive pressure.

    Explanation

    California requires pharmacies that compound sterile preparations to obtain a sterile compounding license from the Board of Pharmacy. This license is in addition to the pharmacy license. Other requirements include adherence to USP standards but not necessarily a full-time microbiologist or automated devices.

  57. Question 57California pharmacy law and jurisprudence

    Under California law, which of the following is required for a prescription to be valid when transmitted by facsimile for a Schedule II controlled substance?

    1. The prescription must be followed by a written prescription within 7 days.
    2. The prescription must be transmitted using a secure electronic system.
    3. The prescription must be transmitted only in an emergency. Correct answer.
    4. The prescription may be transmitted by fax for any Schedule II drug.

    Explanation

    California law allows facsimile transmission of Schedule II prescriptions only in emergency situations. In such cases, the prescriber must provide a written prescription within 7 days. Routine Schedule II prescriptions may not be faxed.

  58. Question 58California pharmacy law and jurisprudence

    A California pharmacy is conducting a self-inspection. Which of the following must be reviewed as part of the inspection?

    1. The pharmacy's advertising materials.
    2. The pharmacy's employee vaccination records.
    3. The pharmacy's utility bills.
    4. The pharmacy's compliance with security requirements for controlled substances. Correct answer.

    Explanation

    Self-inspection in California pharmacies must include a review of compliance with security requirements for controlled substances, among other things. This helps ensure the pharmacy is meeting its legal obligations. Advertising, vaccination records, and utility bills are not part of the required self-inspection.

  59. Question 59California pharmacy law and jurisprudence

    Which of the following is a requirement for a California pharmacist to administer immunizations?

    1. The pharmacist must be certified in basic life support only.
    2. The pharmacist must have a separate immunization license.
    3. The pharmacist must obtain a prescriber's order for each immunization.
    4. The pharmacist must complete a training program approved by the Board of Pharmacy. Correct answer.

    Explanation

    California pharmacists must complete a Board-approved training program to administer immunizations. This training covers vaccine storage, administration, and emergency response. A separate license is not required, and a prescriber's order is not needed for protocol-based immunizations.

  60. Question 60California pharmacy law and jurisprudence

    Under California law, what is the requirement for a pharmacy to provide a patient with a copy of their prescription records?

    1. The pharmacy may refuse to provide a copy to protect patient privacy.
    2. The pharmacy must provide a copy only if ordered by a court.
    3. The pharmacy must provide a copy within 24 hours at no cost.
    4. The pharmacy must provide a copy upon request and may charge a reasonable fee. Correct answer.

    Explanation

    California law allows patients to request copies of their prescription records. The pharmacy must provide them and may charge a reasonable fee for the copies. Refusal is not permitted, and a court order is not required.

  61. Question 61California pharmacy law and jurisprudence

    A California pharmacy receives a prescription for a controlled substance that was written by a prescriber in another state. Which of the following is required for the pharmacist to dispense?

    1. The pharmacist must verify the prescription with the Medical Board of California.
    2. The prescriber must have a valid DEA registration and the prescription must be valid in the prescriber's state. Correct answer.
    3. The prescription must be for a non-controlled drug.
    4. The prescriber must be registered with the California Board of Pharmacy.

    Explanation

    California allows dispensing of controlled substances based on out-of-state prescriptions if the prescriber has a valid DEA registration and the prescription is valid in the state where written. The prescriber does not need to be registered with the California Board of Pharmacy. Verification with the Medical Board is not required.

  62. Question 62California pharmacy law and jurisprudence

    Under California law, a pharmacist may dispense a prescription for a drug that is not FDA-approved but is approved in Canada under which of the following circumstances?

    1. The drug is for personal use and the patient signs a waiver.
    2. The drug is a controlled substance and the prescriber is DEA-registered.
    3. The drug is included on the Board of Pharmacy's list of approved Canadian drugs and the prescription is from a California-licensed prescriber. Correct answer.
    4. The drug is for a life-threatening condition and the patient has a prescription from a Canadian physician.

    Explanation

    California law allows pharmacists to dispense certain Canadian-approved drugs if they are on a list established by the Board of Pharmacy and the prescription is from a California-licensed prescriber. This is a narrow exception. It does not apply to controlled substances or personal use waivers.

  63. Question 63California pharmacy law and jurisprudence

    A California pharmacy uses an automated dispensing system for controlled substances. Which of the following is required?

    1. The system must maintain a record of all transactions and be secured against unauthorized access. Correct answer.
    2. The system must be restocked only by a pharmacist.
    3. The system must have a manual override for emergencies.
    4. The system must be checked by a pharmacist before each dose is removed.

    Explanation

    Automated dispensing systems for controlled substances must maintain a record of all transactions and be secured to prevent unauthorized access. This ensures accountability and security. A pharmacist does not need to check each dose before removal, and restocking can be done by trained personnel.

  64. Question 64California pharmacy law and jurisprudence

    A California pharmacist is asked to dispense a prescription for a controlled substance written by a prescriber who is not registered with the DEA. Which of the following is correct?

    1. The pharmacist may dispense if the prescriber is licensed in California.
    2. The pharmacist must dispense because the prescription is valid on its face.
    3. The pharmacist may dispense if the drug is a Schedule V controlled substance.
    4. The pharmacist may not dispense because the prescriber lacks DEA registration. Correct answer.

    Explanation

    A prescriber must have a valid DEA registration to prescribe controlled substances. A prescription from a prescriber without DEA registration is not valid for a controlled substance. The pharmacist must not dispense.

  65. Question 65California pharmacy law and jurisprudence

    Which of the following is a requirement for a California pharmacy to maintain a drug pedigree for prescription drugs?

    1. A pedigree must be maintained for all prescription drugs.
    2. A pedigree is not required in California.
    3. A pedigree must be maintained for drugs that are not controlled substances. Correct answer.
    4. A pedigree must be maintained only for controlled substances.

    Explanation

    California law requires a drug pedigree for prescription drugs that are not controlled substances. Controlled substances are subject to separate tracking requirements. The pedigree documents the chain of custody from the manufacturer to the pharmacy.

  66. Question 66California pharmacy law and jurisprudence

    Under California law, which of the following is true regarding a pharmacist's ability to dispense a prescription for a Schedule II controlled substance that was transmitted electronically?

    1. Electronic prescriptions for Schedule II are not permitted.
    2. Electronic prescriptions for Schedule II are permitted if they meet DEA requirements. Correct answer.
    3. Electronic prescriptions for Schedule II are permitted only for hospice patients.
    4. Electronic prescriptions for Schedule II require a written follow-up.

    Explanation

    California allows electronic prescriptions for Schedule II controlled substances if they comply with DEA electronic prescription requirements. A written follow-up is not required. The permission is not limited to hospice patients.

  67. Question 67California pharmacy law and jurisprudence

    A California pharmacist is asked to dispense a prescription for a drug that is the subject of a voluntary recall. What is the appropriate action?

    1. Dispense the drug and inform the patient of the recall.
    2. Do not dispense the drug and return it to the manufacturer or dispose of it according to instructions. Correct answer.
    3. Dispense the drug if the recall is Class III.
    4. Dispense the drug only if the prescriber approves.

    Explanation

    Pharmacists should not dispense drugs that are subject to a voluntary recall. The drug should be quarantined and returned to the manufacturer or disposed of according to recall instructions. Informing the patient and dispensing is not appropriate.

  68. Question 68California pharmacy law and jurisprudence

    Which of the following is required for a California pharmacy to provide prescription drugs to patients through a mail-order service?

    1. The pharmacy must obtain a mail-order license from the Board of Pharmacy. Correct answer.
    2. The pharmacy must be located in California.
    3. The pharmacy must provide a toll-free telephone number for patient inquiries.
    4. The pharmacy must deliver all prescriptions within 24 hours.

    Explanation

    California requires pharmacies that provide prescription drugs through mail-order to obtain a mail-order license from the Board of Pharmacy. This license is in addition to the pharmacy license. A toll-free number and 24-hour delivery are not specific requirements.

  69. Question 69California pharmacy law and jurisprudence

    Under California law, what is the requirement for a pharmacy to report the theft of a controlled substance to the Board of Pharmacy?

    1. The theft must be reported within 30 days.
    2. The theft must be reported immediately upon discovery. Correct answer.
    3. The theft must be reported within 7 days of discovery.
    4. The theft must be reported only if the value exceeds $1,000.

    Explanation

    California law requires immediate reporting of the theft of controlled substances to the Board of Pharmacy. This allows for prompt investigation and prevents further diversion. There is no value threshold or 30-day window.

  70. Question 70California pharmacy law and jurisprudence

    Under California law, what is the minimum age for a person to purchase a nonprescription hypodermic needle and syringe from a pharmacy without a prescription?

    1. 18 years of age Correct answer.
    2. 16 years of age
    3. 21 years of age
    4. There is no minimum age

    Explanation

    California permits sale of syringes and needles without a prescription to persons 18 or older for disease-prevention purposes. Younger purchasers require a prescription.

  71. Question 71California pharmacy law and jurisprudence

    In California, a pharmacist's prescription recordkeeping for Schedule II drugs must generally be retained for what minimum period?

    1. 2 years
    2. 3 years Correct answer.
    3. 1 year
    4. 5 years

    Explanation

    California requires prescription records for controlled substances to be maintained for at least three years. This supports inspection and audit by enforcement agencies.

  72. Question 72California pharmacy law and jurisprudence

    Under California law, which person may lawfully perform the final check of a prescription before it is dispensed to a patient?

    1. A pharmacy clerk
    2. A certified pharmacy technician
    3. A licensed pharmacist Correct answer.
    4. A pharmacy intern without supervision

    Explanation

    Final verification of a dispensed prescription is a pharmacist function in California. Technicians and clerks may assist but cannot perform the final professional check.

  73. Question 73California pharmacy law and jurisprudence

    A California pharmacy's license must be renewed on what cycle?

    1. Every two years Correct answer.
    2. Every four years
    3. Every three years
    4. Annually

    Explanation

    California pharmacy licenses are renewed biennially. The Board sets the renewal cycle and fees accordingly.

  74. Question 74California pharmacy law and jurisprudence

    Under California law, a pharmacist must notify the Board of Pharmacy of a change of address within what timeframe?

    1. 90 days
    2. 30 days Correct answer.
    3. 60 days
    4. 10 days

    Explanation

    Licensees must report address changes to the Board within 30 days. Timely notice keeps Board correspondence and enforcement reachable.

  75. Question 75California pharmacy law and jurisprudence

    Which of the following is required before a California pharmacy may begin operating at a new location?

    1. A temporary permit from the county
    2. No action if the owner is unchanged
    3. A new pharmacy license for that location Correct answer.
    4. Only a change-of-address notice

    Explanation

    Each pharmacy location must be separately licensed by the Board. Moving to a new address requires a new license for that premises.

  76. Question 76California pharmacy law and jurisprudence

    Under California law, which of the following best describes the requirement for a pharmacy to keep its license conspicuously displayed?

    1. It need only be available on request
    2. It is not required to be displayed
    3. It may be kept in a locked office
    4. It must be posted in a public area of the pharmacy Correct answer.

    Explanation

    The pharmacy license must be conspicuously displayed where the public can see it. This allows patients to confirm licensure status.

  77. Question 77California pharmacy law and jurisprudence

    A California pharmacist receives a prescription that appears to be forged. What is the pharmacist's most appropriate action under California law?

    1. Dispense a partial quantity
    2. Refer the patient to another pharmacy without documentation
    3. Refuse to dispense and report as required Correct answer.
    4. Dispense it and document the concern

    Explanation

    A pharmacist who reasonably believes a prescription is forged should not dispense it and should report the matter as required. Dispensing a suspected forgery exposes the pharmacist and patient to harm.

  78. Question 78California pharmacy law and jurisprudence

    Under California law, which of the following is required for a pharmacy to provide pharmacist consultation to a patient receiving a new prescription?

    1. Only written materials are required
    2. An offer to counsel must be made in person or by accessible means Correct answer.
    3. Counseling is only required for controlled substances
    4. Counseling may be waived entirely by the pharmacy

    Explanation

    California requires that patients be offered counseling on new prescriptions, in person or by another accessible means. The offer must be documented and meaningful.

  79. Question 79California pharmacy law and jurisprudence

    A California pharmacy wants to use a remote automated dispensing device at a satellite location. Which of the following is generally required?

    1. Board approval of the satellite and compliance with stocking and security rules Correct answer.
    2. A separate DEA registration only
    3. No approval if a pharmacist supervises remotely
    4. Only local fire department approval

    Explanation

    Satellite and automated dispensing arrangements require Board approval and adherence to security and stocking rules. Remote supervision alone does not substitute for licensure.

  80. Question 80California pharmacy law and jurisprudence

    Under California law, a pharmacy intern may perform which of the following tasks?

    1. Independently counsel patients without oversight
    2. Sign off on controlled substance inventories alone
    3. Independently verify prescriptions
    4. Perform duties under the direct supervision of a pharmacist Correct answer.

    Explanation

    Interns may perform pharmacy functions only under pharmacist supervision. Independent verification or unsupervised counseling exceeds the intern's authority.

  81. Question 81California pharmacy law and jurisprudence

    A California pharmacist is asked to dispense a prescription that is missing the prescriber's DEA number for a controlled substance. What is the most appropriate response?

    1. Dispense a 5-day supply
    2. Dispense if the drug is not a controlled substance
    3. Refuse and request a corrected prescription Correct answer.
    4. Dispense and add the DEA number later

    Explanation

    A controlled substance prescription must include the required prescriber identifiers. If they are missing, the pharmacist should obtain a corrected prescription before dispensing.

  82. Question 82California pharmacy law and jurisprudence

    Under California law, which of the following is true regarding a pharmacist's duty to report an adverse event involving a drug dispensed by the pharmacy?

    1. Reporting is voluntary in all cases
    2. Reporting is required only for generic drugs
    3. The pharmacist must report serious adverse events as required by law Correct answer.
    4. Only prescribers may report adverse events

    Explanation

    California and federal frameworks require reporting of serious adverse drug events by responsible parties. Pharmacists play a key role in identifying and reporting these events.

  83. Question 83California pharmacy law and jurisprudence

    A California pharmacy's controlled substance inventory must be conducted how often at minimum?

    1. Every six months
    2. Every two years
    3. Annually Correct answer.
    4. Only when ownership changes

    Explanation

    California requires an inventory of controlled substances at least annually, in addition to inventories triggered by ownership or licensure changes.

  84. Question 84California pharmacy law and jurisprudence

    Under California law, a pharmacist may dispense a prescription for a Schedule II controlled substance in an emergency situation without a written prescription under which condition?

    1. The patient signs a waiver
    2. The prescriber provides an oral order and delivers a written prescription within the required timeframe Correct answer.
    3. The pharmacy notifies the Board within 30 days
    4. The pharmacist documents the emergency in the patient record only

    Explanation

    Emergency oral Schedule II orders are permitted if the prescriber follows up with a written prescription within the required period. Documentation alone does not satisfy the rule.

  85. Question 85California pharmacy law and jurisprudence

    A California pharmacy discovers a significant loss of controlled substances. What is the required action?

    1. Report only if the loss exceeds a set dollar amount
    2. Report the loss to the Board and DEA as required Correct answer.
    3. Report only to the wholesaler
    4. No report is required if internal records are corrected

    Explanation

    Significant losses of controlled substances must be reported to the appropriate authorities, including the Board and DEA. Internal correction of records does not replace reporting.

  86. Question 86California pharmacy law and jurisprudence

    Under California law, which of the following is required for a pharmacy to dispense a prescription for a dangerous drug pursuant to a valid prescription?

    1. The patient must sign a consent form
    2. The prescription must be issued by a licensed prescriber acting within scope Correct answer.
    3. The pharmacy must obtain prior authorization
    4. The prescription must be written on paper

    Explanation

    A valid prescription must come from a licensed prescriber acting within the scope of practice. Paper form, consent, and prior authorization are not universal requirements.

  87. Question 87California pharmacy law and jurisprudence

    A California pharmacy technician is asked to transfer a prescription to another pharmacy. Which of the following is correct?

    1. Only pharmacists may transfer prescriptions Correct answer.
    2. Technicians may transfer prescriptions if the pharmacist authorizes it
    3. Transfers are prohibited entirely
    4. Transfers require Board pre-approval

    Explanation

    Prescription transfers are a pharmacist function in California. A technician may assist but cannot independently effect the transfer.

  88. Question 88California pharmacy law and jurisprudence

    Under California law, which of the following is a requirement for a pharmacist to furnish self-administered hormonal contraception?

    1. Completion of a Board-recognized training program Correct answer.
    2. A physician on site
    3. A separate DEA registration
    4. A hospital affiliation

    Explanation

    California allows pharmacists to furnish certain contraceptives after completing required training. The training ensures competence in screening and counseling.

  89. Question 89California pharmacy law and jurisprudence

    A California pharmacy is cited for failing to maintain a clean and sanitary environment. Which of the following best describes the legal basis for the citation?

    1. Sanitation is a voluntary best practice
    2. Sanitation applies only to sterile compounding
    3. Only federal law addresses sanitation
    4. Board regulations require sanitary conditions for drug storage and dispensing Correct answer.

    Explanation

    Board regulations require pharmacies to maintain sanitary conditions to protect drug integrity and patient safety. The duty applies to all pharmacy operations, not only sterile compounding.

  90. Question 90California pharmacy law and jurisprudence

    Under California law, a pharmacist may decline to dispense a prescription based on a sincerely held moral objection only if the pharmacist does which of the following?

    1. Provides notice and ensures the patient can obtain the drug elsewhere Correct answer.
    2. Reports the patient to the Board
    3. Destroys the prescription
    4. Requires the patient to pay a fee

    Explanation

    California permits conscientious refusal only with safeguards that protect patient access. The pharmacist must provide notice and facilitate access to the medication.

  91. Question 91California pharmacy law and jurisprudence

    Which of the following is required for a California pharmacy to maintain a license when the pharmacist-in-charge leaves the position?

    1. The pharmacy must close immediately
    2. A new PIC must be designated and reported to the Board within the required timeframe Correct answer.
    3. Only the owner must be notified
    4. The pharmacy may operate without a PIC indefinitely

    Explanation

    Pharmacies must have a designated pharmacist-in-charge and must notify the Board of changes. Operating without a PIC is not permitted.

  92. Question 92California pharmacy law and jurisprudence

    Under California law, which of the following best describes the requirement for a pharmacy to maintain a policy on medication errors?

    1. The pharmacy must have a quality assurance program to identify and reduce errors Correct answer.
    2. Errors need only be reported to the patient
    3. No policy is required
    4. Errors are reported only if harm occurs

    Explanation

    California requires pharmacies to maintain a quality assurance program that tracks and works to prevent medication errors. This is broader than patient notification alone.

  93. Question 93California pharmacy law and jurisprudence

    A California pharmacist is asked to dispense a prescription for a drug that requires a patient package insert. What is the pharmacist's obligation?

    1. Provide the insert as required by law Correct answer.
    2. No obligation exists
    3. Provide it only for controlled substances
    4. Provide it only on request

    Explanation

    When federal or state law requires a patient package insert, the pharmacy must provide it with the dispensed drug. The obligation is not limited to request.

  94. Question 94California pharmacy law and jurisprudence

    Under California law, which of the following is true regarding a pharmacy's obligation to report a change in ownership?

    1. The Board must be notified and a new license obtained as required Correct answer.
    2. Only the DEA must be notified
    3. Notification may be delayed until renewal
    4. No action is required if the pharmacy name is unchanged

    Explanation

    Changes in ownership require Board notification and appropriate licensure steps. A change in ownership is not excused by keeping the same name.

  95. Question 95California pharmacy law and jurisprudence

    Under California law, a prescription for a dangerous drug remains valid for dispensing for how long after the date it was written, unless the prescriber specifies otherwise?

    1. One year from the date written Correct answer.
    2. Thirty days from the date written
    3. Six months from the date written
    4. Two years from the date written

    Explanation

    California law treats a prescription for a dangerous drug as valid for one year from the date written unless the prescriber indicates a shorter expiration. After that period the prescription may not be dispensed without new authorization. Controlled substances are governed by separate, generally shorter federal and state limits.

  96. Question 96California pharmacy law and jurisprudence

    A California pharmacy receives a request from a patient to transfer a prescription for a non-controlled drug to another pharmacy. Which statement best reflects California requirements for this transfer?

    1. The transfer may be completed only by a pharmacist and only in an emergency
    2. The transfer may be made only after the patient provides a new written authorization to the receiving pharmacy
    3. The transfer must be documented, and the transferring pharmacy must retain a record of the transfer Correct answer.
    4. The transfer is prohibited unless the original prescriber is notified first

    Explanation

    California permits prescription transfers between pharmacies, including for non-controlled drugs, provided the transfer is properly documented and the transferring pharmacy keeps a record. The patient does not need to obtain new written authorization solely to transfer. Routine transfers are not limited to emergencies, and prescriber notification is not a general precondition.

  97. Question 97California pharmacy law and jurisprudence

    A California pharmacist suspects that a prescriber's order was altered to increase the quantity of a controlled substance. What is the pharmacist's most appropriate response?

    1. Reduce the quantity to what the pharmacist believes is appropriate and dispense
    2. Dispense the prescription as written and note the concern in the patient record
    3. Contact the prescriber to verify the order before dispensing Correct answer.
    4. Hold the prescription indefinitely without notifying anyone

    Explanation

    When a prescription appears altered or otherwise questionable, the pharmacist should verify it with the prescriber before dispensing rather than guessing at the correct order. Dispensing an unverified altered controlled substance order risks patient harm and legal exposure. Simply holding the prescription without any follow-up does not satisfy the pharmacist's professional obligations.

  98. Question 98California pharmacy law and jurisprudence

    Under California law, which of the following best describes the continuing education requirement for pharmacist license renewal?

    1. Thirty hours of continuing education every two years, including a specified portion in pharmacy law Correct answer.
    2. Fifty hours of continuing education every two years with all hours in clinical topics
    3. Ten hours of continuing education every year with no subject requirements
    4. No continuing education is required once a pharmacist has practiced for twenty years

    Explanation

    California requires pharmacists to complete a set number of continuing education hours per renewal cycle, and a portion must address pharmacy law. The requirement applies throughout a pharmacist's career and is not waived by longevity. The other figures misstate the total hours or the subject composition.

  99. Question 99California pharmacy law and jurisprudence

    A California pharmacy wants to provide prescription refills for a dangerous drug beyond the original authorized refills. Which action is most consistent with California law?

    1. Obtain new authorization from the prescriber before dispensing additional refills Correct answer.
    2. Refill the prescription indefinitely as long as the patient requests it
    3. Have the pharmacy technician authorize the additional refills
    4. Dispense a partial quantity and label it as a new prescription

    Explanation

    Refills beyond those authorized on the original prescription require new authorization from the prescriber. The pharmacist cannot extend refill authority independently, and technicians cannot authorize refills. Relabeling a partial fill as a new prescription does not create valid refill authority.

  100. Question 100California pharmacy law and jurisprudence

    A California pharmacy learns that a patient is receiving overlapping prescriptions for two opioid analgesics from different prescribers. Which action best reflects the pharmacist's professional and legal obligations?

    1. Refuse to dispense both prescriptions permanently and close the patient's file
    2. Report the patient to law enforcement before any clinical review
    3. Dispense both prescriptions without comment because each was validly issued
    4. Contact the prescribers to discuss the overlap and document the intervention Correct answer.

    Explanation

    Pharmacists have a corresponding responsibility to review prescriptions for therapeutic duplication and to resolve concerns with prescribers. Documenting the intervention supports both patient safety and legal compliance. Automatically dispensing, permanently refusing care without review, or reporting before clinical assessment are not appropriate first steps.

  101. Question 101Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Under California law, a pharmacist must provide oral patient consultation on a new prescription unless the patient or the patient's agent declines it. Which statement best describes this requirement?

    1. Consultation may be waived permanently by signing a one-time form at the first fill
    2. Consultation is required only for prescriptions dispensed to patients under age 18
    3. The offer must be made in person or by telephone and documented, and the patient may refuse Correct answer.
    4. Consultation is required only when the prescriber requests it in writing

    Explanation

    California requires that a pharmacist offer to discuss the new prescription in person or by telephone, and the offer and any refusal must be documented. The patient retains the right to decline each time. A blanket one-time waiver does not satisfy the requirement.

  102. Question 102Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A prescriber writes an oral order to a pharmacist to change a patient's warfarin dose. What is the most appropriate pharmacist action?

    1. Transfer the call to the pharmacy technician to transcribe
    2. Accept the oral order and document it in the patient record Correct answer.
    3. Refuse all oral orders as a matter of law
    4. Require the patient to obtain a new written prescription before any change

    Explanation

    Pharmacists may accept oral prescription orders, including changes, from a prescriber and must reduce them to writing and document them. The key control is accurate documentation and verification, not refusal.

  103. Question 103Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which element is required on a prescription label for a compounded sterile preparation dispensed to an outpatient?

    1. The cost of each ingredient used
    2. The prescriber's DEA number
    3. The manufacturer's lot number of each ingredient
    4. Beyond-use date and storage conditions Correct answer.

    Explanation

    Labels for compounded preparations must include a beyond-use date and storage conditions so the patient knows when the preparation expires and how to store it. Ingredient cost and ingredient lot numbers are not label requirements, and a DEA number is not required on the label.

  104. Question 104Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacy technician prepares a sterile admixture. Which task must be performed by the pharmacist rather than delegated?

    1. Assembling the supplies for the admixture
    2. Final verification of the compounded sterile product before release Correct answer.
    3. Cleaning the laminar airflow workbench
    4. Recording the room temperature log

    Explanation

    Final verification and release of a compounded sterile preparation is a pharmacist responsibility that cannot be delegated to a technician. Cleaning, supply assembly, and log recording are supportive tasks that may be delegated under supervision.

  105. Question 105Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist receives a prescription for a controlled substance that appears altered in the quantity. What is the most appropriate action?

    1. Dispense a smaller quantity to be safe
    2. Verify the prescription with the prescriber before dispensing Correct answer.
    3. Dispense the quantity as written and note the concern
    4. Return the prescription to the patient without comment

    Explanation

    A pharmacist who suspects a prescription has been altered must verify it with the prescriber before dispensing. Dispensing on a suspected altered prescription exposes the patient and the pharmacy to harm. The concern should be documented.

  106. Question 106Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which practice best supports medication reconciliation at care transitions?

    1. Relying on the discharge summary alone as the medication list
    2. Comparing the patient's pre-admission list with discharge orders and resolving discrepancies Correct answer.
    3. Providing a refill reminder call after discharge
    4. Reviewing only the medications the patient reports taking

    Explanation

    Medication reconciliation is a formal process of comparing the prior medication list with new orders and resolving discrepancies. It requires obtaining a best possible medication history, not just relying on patient recall or a single document.

  107. Question 107Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is counseling a patient starting a new inhaler. Which counseling point is most important for correct technique?

    1. Tell the patient to store the inhaler in the refrigerator
    2. Demonstrate and have the patient perform a return demonstration Correct answer.
    3. Advise the patient to rinse the mouth only after using a steroid inhaler
    4. Instruct the patient to shake all inhalers before every use

    Explanation

    Return demonstration confirms the patient can perform the technique correctly and is the most effective counseling method for devices. Not all inhalers require refrigeration or shaking, and mouth rinsing applies specifically to inhaled corticosteroids.

  108. Question 108Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which action is required when a pharmacist discovers that an error was made in dispensing a prescription that reached the patient?

    1. Wait for the patient to report a problem
    2. Correct the record and take no further action
    3. Discuss the error only with pharmacy staff
    4. Assess the patient, notify the prescriber, and document the event Correct answer.

    Explanation

    A dispensing error that reaches the patient requires patient assessment, prescriber notification, and documentation as part of the medication safety process. Correcting the record alone does not address patient harm or support learning.

  109. Question 109Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is verifying a prescription for methotrexate written as a daily dose for rheumatoid arthritis. What is the most appropriate action?

    1. Change the frequency to weekly and dispense without contacting the prescriber
    2. Dispense a smaller quantity and counsel the patient
    3. Contact the prescriber to clarify the dosing frequency before dispensing Correct answer.
    4. Dispense as written because the prescriber signed it

    Explanation

    Methotrexate for rheumatoid arthritis is dosed weekly, and a daily order raises a serious safety concern requiring clarification with the prescriber. The pharmacist must resolve the discrepancy before dispensing rather than altering therapy unilaterally.

  110. Question 110Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which statement accurately describes the pharmacist's role in therapeutic interchange under a hospital protocol?

    1. Interchange requires a new prescription for every dose
    2. Interchange may be done for any drug at the pharmacist's discretion
    3. Interchange is prohibited in all inpatient settings
    4. Interchange is permitted under an approved protocol that specifies criteria and documentation Correct answer.

    Explanation

    Therapeutic interchange is authorized through an approved protocol that defines which agents may be substituted, the criteria, and the required documentation. It is not discretionary for any drug and does not require a new prescription for each dose.

  111. Question 111Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A patient brings in a prescription for a Schedule II controlled substance that was issued 45 days ago. What is the most appropriate pharmacist response?

    1. Do not dispense and contact the prescriber for a new prescription Correct answer.
    2. Dispense it because Schedule II prescriptions never expire
    3. Dispense half the quantity
    4. Dispense it after adding a note to the record

    Explanation

    A Schedule II prescription is generally not valid beyond the period specified by state law, and a prescription that old cannot be filled as written. The pharmacist should decline and ask the prescriber for a current prescription.

  112. Question 112Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which practice most directly reduces the risk of a wrong-patient error at the dispensing counter?

    1. Using at least two patient identifiers before dispensing Correct answer.
    2. Checking the address on file
    3. Asking the patient to confirm the drug name
    4. Relying on the prescription number alone

    Explanation

    Using two independent patient identifiers at the point of dispensing is a standard safeguard against wrong-patient errors. Confirming the drug name or relying on a single identifier does not reliably confirm identity.

  113. Question 113Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is preparing to dispense a high-alert medication. Which practice best reflects safe handling of high-alert medications?

    1. Relying on the prescriber's calculation
    2. Dispensing with a verbal warning to the patient
    3. Single verification by the same person who prepared it
    4. Independent double-check of the dose calculation and product before release Correct answer.

    Explanation

    An independent double-check by a second qualified person reduces the risk of error with high-alert medications. Self-verification, verbal warnings alone, and reliance on the prescriber's calculation do not provide independent verification.

  114. Question 114Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which documentation is required when a pharmacist dispenses a prescription by telephone from a prescriber?

    1. The technician records the order without pharmacist review
    2. Only the drug name and quantity are recorded
    3. The pharmacist records the order and the prescriber's identity and documents it Correct answer.
    4. No documentation is needed if the patient is known

    Explanation

    An oral prescription must be reduced to writing by the pharmacist with the prescriber's identity and the details of the order documented. The pharmacist, not a technician, is responsible for receiving and documenting it.

  115. Question 115Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A patient reports a new rash after starting a new medication. What is the pharmacist's most appropriate action?

    1. Tell the patient to continue the medication and monitor
    2. Assess the reaction, advise the patient, and report it to the prescriber Correct answer.
    3. Recommend an over-the-counter antihistamine and take no further action
    4. Discontinue the medication without contacting the prescriber

    Explanation

    The pharmacist should assess the reaction, provide advice, and communicate with the prescriber about a possible adverse drug reaction. Unilateral discontinuation or treating without follow-up can delay appropriate care.

  116. Question 116Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which step is essential when a pharmacist compounds a nonsterile preparation from a bulk ingredient?

    1. Weigh ingredients by volume rather than mass
    2. Use the ingredient past its expiration if it still looks normal
    3. Skip the master formulation record for small batches
    4. Verify the ingredient identity, strength, and expiration before use Correct answer.

    Explanation

    Compounding requires verifying each ingredient's identity, strength, and expiration date before use. Using expired ingredients, skipping the master formulation record, or measuring by volume instead of mass compromises quality.

  117. Question 117Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is counseling a patient on a new anticoagulant. Which counseling point is most important to reduce bleeding risk?

    1. Double the dose if a dose is missed
    2. Stop the medication if bruising occurs
    3. Take the medication with grapefruit juice
    4. Recognize signs of bleeding and when to seek care Correct answer.

    Explanation

    Patients on anticoagulants must be able to recognize bleeding signs and know when to seek care, which is central to safe use. Grapefruit interactions, dose doubling, and stopping therapy on bruising are unsafe or incorrect.

  118. Question 118Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which action best supports the safe use of a narrow therapeutic index drug dispensed as a new formulation?

    1. Counsel the patient on the change and monitor for altered response Correct answer.
    2. Withhold counseling to avoid confusing the patient
    3. Increase the dose to compensate for the change
    4. Assume the new formulation is interchangeable without counseling

    Explanation

    For narrow therapeutic index drugs, a formulation change warrants counseling and monitoring for altered response. Assuming interchangeability without counseling or adjusting the dose without prescriber input is unsafe.

  119. Question 119Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacy technician is asked to counsel a patient on a new prescription. What is the appropriate response?

    1. The technician may counsel and have the pharmacist sign the record
    2. The pharmacist must provide the counseling Correct answer.
    3. The technician may counsel if the patient agrees
    4. The technician may counsel if the pharmacist is busy

    Explanation

    Patient counseling is a pharmacist responsibility and may not be delegated to a technician. Having a pharmacist sign a record after technician counseling does not satisfy the requirement.

  120. Question 120Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which practice is most appropriate for managing look-alike/sound-alike medications on the shelf?

    1. Relying on staff familiarity with the products
    2. Removing the original labels to reduce clutter
    3. Storing them next to each other for convenience
    4. Separate storage with prominent auxiliary warning labels Correct answer.

    Explanation

    Separating look-alike/sound-alike products and using tall-man lettering or warning labels reduces selection errors. Adjacent storage, familiarity, and label removal increase risk.

  121. Question 121Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist receives a prescription for a drug that is contraindicated with a medication the patient is already taking. What is the most appropriate action?

    1. Dispense the drug and reduce the dose of the existing medication
    2. Contact the prescriber to discuss an alternative before dispensing Correct answer.
    3. Dispense the drug and monitor for adverse effects
    4. Dispense the drug and warn the patient of the interaction

    Explanation

    A contraindicated combination requires prescriber contact to discuss an alternative before dispensing. Dispensing with a warning, unilateral dose adjustment, or monitoring alone does not address the contraindication.

  122. Question 122Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is reviewing a prescription for a pediatric patient with a weight-based dose that appears high. Which action best reflects safe practice?

    1. Dispense the dose as written because pediatrics is outside the pharmacist's role
    2. Ask the parent to confirm the dose is correct
    3. Reduce the dose by 10% without contacting the prescriber
    4. Recalculate the dose using the documented weight and clarify with the prescriber Correct answer.

    Explanation

    The pharmacist should recalculate the weight-based dose using the documented weight and clarify any discrepancy with the prescriber. Reducing the dose unilaterally or relying on a parent's confirmation is not appropriate.

  123. Question 123Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacy discovers that a look-alike product was dispensed in place of the prescribed drug. Which sequence best reflects an effective safety response?

    1. Document the event and continue normal operations
    2. Notify the prescriber only if the patient reports harm
    3. Replace the product without notifying anyone
    4. Assess the patient, notify the prescriber, retrieve the product, and document and analyze the event Correct answer.

    Explanation

    An effective response includes patient assessment, prescriber notification, retrieval of the incorrect product, and documentation with analysis to prevent recurrence. Partial responses fail to protect the patient or improve the system.

  124. Question 124Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is asked to verify a compounded sterile preparation with a beyond-use date that exceeds the stability data for the preparation. What is the most appropriate action?

    1. Extend the date if the preparation looks clear
    2. Assign a beyond-use date supported by stability data and documented rationale Correct answer.
    3. Use the requested date because the prescriber asked for it
    4. Use the manufacturer's expiration date of the bulk drug

    Explanation

    A beyond-use date must be supported by stability data and documented rationale for the specific preparation and storage conditions. Prescriber request, visual appearance, or the bulk drug's expiration date cannot justify an unsupported date.

  125. Question 125Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is designing a workflow to reduce dispensing errors during peak volume. Which intervention has the strongest evidence for reducing errors?

    1. Relying on the patient to catch errors at pickup
    2. Adding a second verbal confirmation by the same person
    3. Increasing the number of prescriptions processed per hour
    4. Standardizing the verification process with barcode scanning at dispensing Correct answer.

    Explanation

    Standardized verification with barcode scanning provides an independent technology check that reduces selection and dispensing errors. Self-confirmation, speed pressure, and patient detection are weaker or counterproductive safeguards.

  126. Question 126Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist receives a new prescription for a patient and notes that the patient is already taking a medication that is a strong CYP3A4 inhibitor. Which action should the pharmacist take first?

    1. Advise the patient to reduce the dose of the interacting medication.
    2. Dispense the prescription as written and counsel the patient on potential side effects.
    3. Contact the prescriber to discuss the interaction and recommend an alternative. Correct answer.
    4. Document the interaction in the patient profile and proceed with dispensing.

    Explanation

    Pharmacists have a professional responsibility to identify and resolve clinically significant drug interactions before dispensing. Contacting the prescriber allows for a collaborative decision on therapy, which may include selecting an alternative agent or adjusting doses. Dispensing without intervention could expose the patient to harm.

  127. Question 127Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a required element of a prescription for a controlled substance in Schedule II?

    1. The prescriber's DEA number Correct answer.
    2. The pharmacy's NPI number
    3. The patient's insurance information
    4. The patient's diagnosis code

    Explanation

    A valid prescription for a Schedule II controlled substance must include the prescriber's DEA number, which is required for the pharmacy to verify the prescriber's authority to prescribe controlled substances. Diagnosis codes and insurance information are not legal requirements for the prescription itself.

  128. Question 128Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    When compounding a nonsterile oral suspension from a commercial product, which practice is essential to ensure uniformity and accurate dosing?

    1. Shaking the final preparation thoroughly before dispensing Correct answer.
    2. Storing the preparation at room temperature regardless of stability
    3. Adding the vehicle before the active ingredient
    4. Using the commercial product's original container for mixing

    Explanation

    Uniform distribution of the drug in a suspension is critical for accurate dosing. Thorough shaking of the final preparation ensures the patient can obtain a homogeneous dose. Compounding guidelines emphasize proper mixing and labeling with instructions to shake well.

  129. Question 129Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A patient asks the pharmacist whether a new over-the-counter supplement will interact with her warfarin. Which response is most appropriate?

    1. Advise her to stop taking warfarin before starting the supplement.
    2. Review the supplement's ingredients and check for known interactions with warfarin. Correct answer.
    3. Tell her that OTC supplements are generally safe and do not interact with prescription drugs.
    4. Recommend that she take the supplement at a different time of day to avoid interaction.

    Explanation

    Pharmacists must evaluate potential interactions between OTC products and prescription medications, especially for drugs with a narrow therapeutic index like warfarin. Reviewing the supplement's ingredients allows for an informed assessment. Simply timing doses apart does not prevent many interactions.

  130. Question 130Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a key component of a pharmacist's patient counseling session for a new prescription?

    1. Comparing the medication to other similar drugs on the market
    2. Discussing the medication's purpose, administration, and potential side effects Correct answer.
    3. Instructing the patient to disregard the package insert
    4. Providing the wholesale cost of the medication

    Explanation

    Patient counseling should cover the purpose of the medication, how to take it, and what side effects to watch for, as these are essential for safe and effective use. Cost and market comparisons are not core counseling elements.

  131. Question 131Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is reviewing a prescription for a patient with a documented allergy to penicillin. The prescribed antibiotic is amoxicillin. What is the most appropriate action?

    1. Substitute azithromycin without contacting the prescriber.
    2. Dispense the amoxicillin with a warning to the patient.
    3. Contact the prescriber to recommend a non-penicillin alternative. Correct answer.
    4. Dispense the amoxicillin because the allergy may be outdated.

    Explanation

    Amoxicillin is a penicillin antibiotic and is contraindicated in patients with a penicillin allergy. The pharmacist should contact the prescriber to discuss an alternative. Dispensing the medication or substituting without authorization could cause harm and is not appropriate.

  132. Question 132Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a requirement for the proper use of an automated dispensing cabinet (ADC) in a hospital?

    1. Medications must be stocked without regard to look-alike/sound-alike names.
    2. Access must be restricted to authorized personnel using unique login credentials. Correct answer.
    3. The cabinet must be restocked only by pharmacy technicians.
    4. Only pharmacists may access the cabinet.

    Explanation

    ADCs must be secured to prevent unauthorized access, and each user should have unique credentials to maintain accountability. This helps track who removed which medications and reduces errors. Restricting access to pharmacists only is not practical in most hospitals.

  133. Question 133Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    When a pharmacist receives a prescription for a medication that requires a prior authorization, what is the most appropriate initial action?

    1. Substitute a similar medication that does not require prior authorization.
    2. Inform the patient that the medication cannot be dispensed and suggest an OTC alternative.
    3. Contact the prescriber to initiate the prior authorization process. Correct answer.
    4. Dispense the medication and bill the patient later.

    Explanation

    Prior authorization requires the prescriber to provide clinical information to the insurer. The pharmacist should contact the prescriber to start this process. Dispensing without approval may result in non-reimbursement, and substituting without authorization is not appropriate.

  134. Question 134Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is verifying a prescription for a high-alert medication. Which of the following is a recommended safety practice?

    1. Relying on memory for dosing calculations
    2. Using a separate, clearly labeled storage area for high-alert medications Correct answer.
    3. Dispensing the medication without a second check
    4. Allowing the prescriber to administer the first dose

    Explanation

    High-alert medications carry a heightened risk of harm and should be stored in a separate, clearly labeled area to reduce the chance of selection errors. Independent double-checks and standardized protocols are also recommended.

  135. Question 135Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following best describes the pharmacist's role in medication therapy management (MTM)?

    1. Dispensing medications without reviewing the patient's full medication list
    2. Conducting comprehensive medication reviews and developing a plan to resolve medication-related problems Correct answer.
    3. Referring all patients to a physician for medication management
    4. Providing only disease-specific education without follow-up

    Explanation

    MTM involves a comprehensive review of all medications a patient is taking to identify and resolve medication-related problems, often in collaboration with other healthcare providers. It includes developing and monitoring a care plan.

  136. Question 136Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A patient presents a prescription for a Schedule II opioid that was electronically prescribed. Which of the following is true regarding electronic prescriptions for controlled substances?

    1. Electronic prescriptions for Schedule II drugs do not require a DEA number.
    2. Electronic prescriptions for Schedule II drugs are not permitted.
    3. The prescriber must use an EHR that meets DEA requirements for electronic prescribing of controlled substances. Correct answer.
    4. The pharmacist must verify the prescription by calling the prescriber for all Schedule II electronic prescriptions.

    Explanation

    The DEA allows electronic prescribing of controlled substances if the prescriber uses a certified EHR system that meets specific security requirements. A DEA number is still required, and routine call verification is not mandated.

  137. Question 137Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    When performing a final check on a compounded sterile preparation (CSP), which of the following is a critical step?

    1. Checking that the beyond-use date is based on the compounding date
    2. Confirming that the preparation was compounded in a laminar airflow hood
    3. Verifying that the correct label includes the patient's diagnosis
    4. Ensuring the preparation is clear and free of particulates Correct answer.

    Explanation

    Visual inspection for particulates and clarity is a required final check for CSPs to ensure the preparation is free from contamination or precipitation. The beyond-use date should be based on stability data and compounding conditions, not simply the compounding date.

  138. Question 138Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is counseling a patient on a new prescription for a medication that should be taken on an empty stomach. Which instruction is most appropriate?

    1. Take the medication 1 hour before or 2 hours after a meal. Correct answer.
    2. Take the medication at bedtime regardless of meals.
    3. Take the medication with a glass of milk.
    4. Take the medication with a full meal to reduce stomach upset.

    Explanation

    Taking a medication on an empty stomach generally means administering it 1 hour before or 2 hours after eating to ensure optimal absorption. Taking with food or milk can alter absorption for some drugs.

  139. Question 139Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a key element of a pharmacy's continuous quality improvement (CQI) program for medication safety?

    1. Limiting error reporting to pharmacists only
    2. Focusing only on individual errors without analyzing system causes
    3. Encouraging reporting of errors and near misses without punitive action Correct answer.
    4. Reviewing errors annually rather than in real time

    Explanation

    A nonpunitive reporting culture encourages staff to report errors and near misses, which allows the pharmacy to identify system issues and implement improvements. CQI emphasizes system analysis rather than blaming individuals.

  140. Question 140Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is asked to dispense a medication that is not commercially available and must be compounded. Which of the following must be included on the label of the compounded preparation?

    1. The name of the manufacturer of the active ingredient
    2. The wholesale cost of the preparation
    3. The patient's insurance policy number
    4. The name and strength of the preparation, and the beyond-use date Correct answer.

    Explanation

    Compounded preparation labels must include the name and strength of the preparation, the beyond-use date, and other required information such as storage conditions and dosage instructions. Manufacturer and financial information are not required.

  141. Question 141Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following best describes the pharmacist's responsibility regarding the reporting of adverse drug reactions (ADRs) to the FDA?

    1. Only manufacturers are required to report ADRs.
    2. Pharmacists are not required to report ADRs.
    3. ADRs should be reported only to the patient's prescriber.
    4. Pharmacists should report serious ADRs to the FDA via the MedWatch program. Correct answer.

    Explanation

    Pharmacists play a key role in post-marketing surveillance by reporting serious adverse drug reactions to the FDA through the MedWatch program. This helps identify new safety signals.

  142. Question 142Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A patient is prescribed a medication that is a known teratogen. Which action is most appropriate for the pharmacist to take before dispensing?

    1. Dispense the medication only if the patient signs a waiver.
    2. Dispense the medication and advise the patient to avoid pregnancy.
    3. Verify that the patient is not pregnant and counsel on the need for effective contraception. Correct answer.
    4. Refer the patient to a genetic counselor without dispensing.

    Explanation

    For teratogenic medications, pharmacists should confirm pregnancy status and ensure the patient understands the need for reliable contraception. This is part of risk evaluation and mitigation strategies (REMS) for some drugs.

  143. Question 143Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a requirement for a pharmacy to maintain its license to dispense controlled substances?

    1. Registration with the DEA Correct answer.
    2. Certification by the Joint Commission
    3. Membership in a professional pharmacy association
    4. Accreditation by the National Association of Boards of Pharmacy

    Explanation

    Pharmacies must be registered with the DEA to dispense controlled substances. This registration is separate from professional memberships or accreditations.

  144. Question 144Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    When a pharmacist discovers that a patient has been receiving duplicate therapy with two NSAIDs, which action is most appropriate?

    1. Contact the prescriber to discuss discontinuing one of the NSAIDs. Correct answer.
    2. Advise the patient to take both at reduced doses.
    3. Document the duplication and take no further action.
    4. Continue both medications and monitor for side effects.

    Explanation

    Duplicate therapy with NSAIDs increases the risk of gastrointestinal bleeding and renal toxicity. The pharmacist should contact the prescriber to resolve the duplication. Simply monitoring or reducing doses without prescriber input is not appropriate.

  145. Question 145Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a key difference between sterile and nonsterile compounding?

    1. Sterile compounding is only performed in hospitals.
    2. Nonsterile compounding requires a cleanroom, while sterile compounding does not.
    3. Nonsterile compounding does not require any quality assurance.
    4. Sterile compounding requires an ISO Class 5 environment, while nonsterile compounding does not. Correct answer.

    Explanation

    Sterile compounding must be performed in an ISO Class 5 environment (e.g., laminar airflow hood) to prevent microbial contamination. Nonsterile compounding does not require this level of environmental control.

  146. Question 146Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is reviewing a prescription for a patient with renal impairment. Which of the following is the most appropriate action to ensure safe dosing?

    1. Refer the patient to a nephrologist before dispensing.
    2. Dispense the standard dose because renal impairment does not affect drug dosing.
    3. Calculate the patient's creatinine clearance and adjust the dose if necessary. Correct answer.
    4. Advise the patient to drink more water to flush the drug.

    Explanation

    Many drugs are renally eliminated and require dose adjustment in renal impairment. Calculating creatinine clearance helps determine the appropriate dose. Standard dosing may lead to toxicity.

  147. Question 147Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following best describes the purpose of a medication error reporting system?

    1. To satisfy insurance requirements only
    2. To compare error rates among pharmacists
    3. To punish individuals who make errors
    4. To identify system failures and prevent future errors Correct answer.

    Explanation

    Medication error reporting systems are designed to identify underlying system failures and implement changes to prevent recurrence. A nonpunitive approach encourages reporting and learning.

  148. Question 148Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is evaluating a prescription for a patient with a history of angioedema while taking an ACE inhibitor. The new prescription is for an ARB. Which action is most appropriate?

    1. Contact the prescriber to discuss the risk of cross-reactivity and consider an alternative. Correct answer.
    2. Dispense the ARB because cross-reactivity is not a concern.
    3. Advise the patient to take an antihistamine with the ARB.
    4. Dispense the ARB with a warning to the patient.

    Explanation

    Patients with a history of ACE inhibitor-induced angioedema may have an increased risk of angioedema with ARBs due to cross-reactivity. The prescriber should be consulted to weigh the risks and consider alternative therapy.

  149. Question 149Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a critical element of a pharmacy's policy for handling investigational drug products?

    1. Maintaining detailed records of receipt, dispensing, and disposal Correct answer.
    2. Dispensing investigational drugs without informed consent documentation
    3. Allowing any pharmacist to dispense without protocol review
    4. Storing investigational drugs with commercial stock

    Explanation

    Investigational drugs require strict accountability, including detailed records of receipt, dispensing, and disposal, to ensure compliance with research protocols and regulations. They should be stored separately from commercial stock.

  150. Question 150Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is reviewing a prescription for a patient with a history of QT prolongation. The prescribed medication is known to prolong the QT interval. Which action is most appropriate?

    1. Dispense the medication with a warning to avoid strenuous exercise.
    2. Dispense the medication and order an ECG before the first dose.
    3. Reduce the dose by half without consulting the prescriber.
    4. Contact the prescriber to discuss the risk and consider an alternative medication. Correct answer.

    Explanation

    For patients with a history of QT prolongation, medications that further prolong the QT interval should be avoided or used with caution. The pharmacist should contact the prescriber to discuss alternatives or risk mitigation strategies.

  151. Question 151Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist receives a verbal prescription for a Schedule III medication from a prescriber. Under federal law, which requirement must be met for this prescription to be valid?

    1. The prescription is invalid because Schedule III drugs may never be ordered verbally
    2. The pharmacist must obtain a new prescription from the prescriber before dispensing any quantity
    3. The prescription must be reduced to writing and signed by the prescriber within a defined period Correct answer.
    4. The prescription must be cosigned by a second pharmacist before it is dispensed

    Explanation

    Federal law permits verbal orders for Schedule III through V drugs, but the prescriber must furnish a written, signed prescription within a specified timeframe. The pharmacist documents the verbal order and follows up to obtain the written record.

  152. Question 152Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which element is required on the prescription label of a dispensed medication under standard pharmacy practice?

    1. The name and address of the dispensing pharmacy Correct answer.
    2. The wholesale acquisition cost of the product
    3. The prescriber's DEA registration number
    4. The manufacturer's lot number

    Explanation

    Prescription labels must identify the dispensing pharmacy by name and address along with directions, patient name, drug name and strength, quantity, and date. Cost data, DEA numbers, and lot numbers are not label requirements.

  153. Question 153Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is counseling a patient starting warfarin. Which counseling point is most important to include?

    1. The patient should keep vitamin K intake consistent and report signs of bleeding Correct answer.
    2. The patient should avoid all green vegetables while taking the drug
    3. The patient should stop the drug immediately if any bruising occurs
    4. The patient should double the next dose if one dose is missed

    Explanation

    Warfarin's effect is influenced by vitamin K intake, so patients should keep intake steady rather than eliminate it. Patients must also be taught to recognize and report bleeding or bruising that suggests over-anticoagulation.

  154. Question 154Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which practice best supports accurate identification of a patient before dispensing a prescription?

    1. Relying on the prescription being handed to the correct window
    2. Confirming identity with a single spoken surname
    3. Using at least two patient identifiers such as name and date of birth Correct answer.
    4. Checking only that the patient knows the medication name

    Explanation

    Patient safety standards call for at least two independent identifiers, commonly full name and date of birth, before dispensing or administering medications. A single identifier or an assumption based on workflow position is insufficient.

  155. Question 155Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is preparing to dispense a look-alike/sound-alike medication pair that has been flagged as high risk. Which action best reflects safe practice?

    1. Storing the two products adjacent to improve efficiency
    2. Using tall-man lettering and separate storage to distinguish the products Correct answer.
    3. Relying on the prescriber's handwriting to differentiate the drugs
    4. Dispensing both products together to reduce future trips

    Explanation

    Tall-man lettering, physical separation, and auxiliary labeling are recognized strategies for reducing selection errors with look-alike/sound-alike products. These controls address the point where mix-ups most often occur.

  156. Question 156Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which statement correctly describes the pharmacist's responsibility when a medication error reaches a patient?

    1. The error should be documented only if the patient files a complaint
    2. The error should be corrected silently to avoid alarming the patient
    3. The error should be reported only to the prescriber, not internally
    4. The error should be disclosed to the patient and reported through the institution's safety system Correct answer.

    Explanation

    Ethical and safety standards require disclosure of harmful errors to the patient and reporting through the organization's event reporting system to support learning. Internal reporting is separate from and additional to communication with the prescriber.

  157. Question 157Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is verifying a prescription written for a pediatric patient. Which calculation approach is most appropriate for determining the dose?

    1. Extrapolating the adult dose by halving it
    2. Applying a fixed fraction of adult dose regardless of weight
    3. Using a weight-based dose and verifying against the maximum adult dose Correct answer.
    4. Using the child's age in years as the sole dosing basis

    Explanation

    Pediatric dosing is generally weight-based (mg/kg) and must be checked against the maximum adult dose to avoid exceeding safe limits. Age alone or simple fractions of adult doses do not account for individual differences in weight and development.

  158. Question 158Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a required component of a prescription for a controlled substance dispensed in a pharmacy?

    1. The drug's therapeutic class
    2. The patient's preferred pharmacy location
    3. The patient's insurance member number
    4. The date of issue and the prescriber's signature Correct answer.

    Explanation

    A valid prescription must include the date of issue and the prescriber's signature, along with patient, drug, and prescriber information. Insurance details and therapeutic class are not prescription requirements.

  159. Question 159Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is asked to dispense a medication whose labeling includes a boxed warning. What does the boxed warning indicate?

    1. The drug carries a serious or life-threatening risk that requires attention Correct answer.
    2. The drug is available only through a restricted distribution program
    3. The drug has been withdrawn from the market
    4. The drug is contraindicated in all patients

    Explanation

    A boxed warning highlights serious or life-threatening adverse effects and is the strongest warning a product label carries. It does not by itself make a drug contraindicated in everyone or mean it has been withdrawn.

  160. Question 160Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which practice is most consistent with safe use of a high-alert medication such as intravenous insulin?

    1. Storing the product in an unlabeled bin for quick access
    2. Using a standard concentration without confirming the order
    3. Independent double-check of the dose and pump settings by a second clinician Correct answer.
    4. Relying on a single clinician's calculation to save time

    Explanation

    High-alert medications warrant independent double-checks of dose, concentration, and delivery settings before administration. Independent verification catches errors that a single check may miss.

  161. Question 161Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A patient reports taking an over-the-counter product in addition to prescribed medications. Why is it important for the pharmacist to document this?

    1. OTC products must be billed through the prescription benefit
    2. OTC products can interact with prescription drugs and affect therapy Correct answer.
    3. OTC products are exempt from interaction screening
    4. OTC products are always safe because they lack a prescription

    Explanation

    Nonprescription products can cause clinically significant interactions and adverse effects, so they belong in the medication record for screening. Assuming OTC products are harmless is a common source of preventable harm.

  162. Question 162Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is the primary purpose of a pharmacist's medication reconciliation at care transitions?

    1. To identify and resolve discrepancies between medication lists Correct answer.
    2. To reduce the number of medications to the lowest possible count
    3. To replace the prescriber's medication orders
    4. To determine which medications the insurer will cover

    Explanation

    Medication reconciliation compares the patient's current medications with new orders to find and correct discrepancies such as omissions, duplications, and dose changes. The goal is accuracy across transitions, not simply fewer medications.

  163. Question 163Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is reviewing a prescription for a patient with a documented sulfa allergy. Which action is most appropriate before dispensing?

    1. Substitute a different drug without contacting the prescriber
    2. Dispense the drug because cross-reactivity is never clinically relevant
    3. Assess the specific agent and allergy history to determine risk Correct answer.
    4. Ignore the allergy because it is not a true allergy

    Explanation

    The pharmacist should clarify the nature of the reaction and the specific product involved, because cross-reactivity varies across sulfonamide-containing drugs. An informed assessment guides whether to dispense, monitor, or contact the prescriber.

  164. Question 164Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following best describes the role of a pharmacy technician in the dispensing process?

    1. Technicians may perform tasks delegated by the pharmacist under appropriate supervision Correct answer.
    2. Technicians may verify the clinical appropriateness of a prescription
    3. Technicians may approve prescriber substitutions without review
    4. Technicians may independently counsel patients on new prescriptions

    Explanation

    Technicians support dispensing through delegated tasks while the pharmacist retains responsibility for clinical judgment and final verification. Patient counseling and clinical review are reserved for the pharmacist.

  165. Question 165Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is preparing to dispense a refrigerated biologic. Which handling practice is most appropriate?

    1. Storing the product at room temperature after receipt
    2. Removing the product from its original carton for storage
    3. Freezing the product to extend its shelf life
    4. Maintaining the manufacturer-specified temperature range and avoiding freeze-thaw cycles Correct answer.

    Explanation

    Biologics are temperature-sensitive and must be stored within the manufacturer's specified range, with protection from freezing unless labeled otherwise. Freeze-thaw cycling and improper storage can degrade the product.

  166. Question 166Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a key element of a prescription monitoring program review by a pharmacist?

    1. Reviewing the patient's immunization record
    2. Verifying the patient's insurance eligibility
    3. Confirming the patient's preferred brand of medication
    4. Checking the patient's controlled-substance history across pharmacies and prescribers Correct answer.

    Explanation

    Prescription monitoring programs allow pharmacists to review controlled-substance dispensing history to identify potential misuse, duplication, or unsafe combinations. Insurance, immunization, and brand preference are unrelated to this review.

  167. Question 167Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is asked to dispense a medication for an off-label indication. What is the most appropriate professional response?

    1. Refuse to dispense because off-label use is prohibited
    2. Report the prescriber to the licensing board automatically
    3. Dispense after confirming the prescription is valid and clinically reasonable Correct answer.
    4. Dispense only if the patient signs a waiver

    Explanation

    Off-label prescribing is lawful and common when supported by evidence and clinical judgment. The pharmacist's role is to verify the prescription's validity and assess whether the use is clinically reasonable.

  168. Question 168Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following best describes the purpose of a medication use evaluation (MUE)?

    1. To assess whether medications are used appropriately and to improve outcomes Correct answer.
    2. To calculate the pharmacy's inventory turnover
    3. To determine staff scheduling needs
    4. To evaluate the pharmacy's physical layout

    Explanation

    An MUE systematically evaluates medication use against criteria to identify opportunities for improving safety, efficacy, and outcomes. It is a clinical quality activity rather than an operational or financial one.

  169. Question 169Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is verifying a compounded nonsterile preparation. Which record is most important to retain?

    1. The prescriber's office hours
    2. The pharmacy's marketing materials
    3. The master formulation record and the compounding log Correct answer.
    4. The patient's insurance card copy

    Explanation

    Nonsterile compounding requires a master formulation record and documentation of each preparation, including components, quantities, and personnel. These records support traceability and quality assurance.

  170. Question 170Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is the most appropriate action when a pharmacist identifies a potential drug interaction of moderate severity?

    1. Change the dose without informing the prescriber
    2. Automatically refuse to dispense any interacting medication
    3. Dispense without comment because moderate interactions are never significant
    4. Evaluate the clinical significance and determine whether monitoring or prescriber contact is needed Correct answer.

    Explanation

    Interaction severity must be interpreted in the context of the patient, dose, and clinical situation. The pharmacist assesses significance and decides whether monitoring, counseling, or prescriber communication is warranted.

  171. Question 171Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A patient asks the pharmacist whether a new prescription can be taken with alcohol. Which response best reflects appropriate counseling?

    1. The patient should decide without pharmacist input
    2. The pharmacist should tell the patient to stop all medications
    3. Alcohol never interacts with prescription medications
    4. The pharmacist should assess the specific drug and provide individualized guidance Correct answer.

    Explanation

    Alcohol can interact with many drug classes through additive CNS effects or metabolic pathways, so guidance must be tailored to the specific medication. A blanket statement either way is inaccurate.

  172. Question 172Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a required practice for a pharmacy handling a drug subject to a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use?

    1. Dispensing the drug without any documentation
    2. Verifying that prescriber and patient requirements are met before dispensing Correct answer.
    3. Skipping the REMS check for refill prescriptions
    4. Dispensing only to patients who pay cash

    Explanation

    REMS with elements to assure safe use require that specified prescriber, patient, and pharmacy requirements be verified before each dispensing. Documentation of these checks is part of compliance.

  173. Question 173Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist discovers a significant dispensing error that has already reached the patient but caused no apparent harm. Which action is most consistent with a just-culture approach?

    1. Report the event and analyze contributing system factors Correct answer.
    2. Punish the individual without examining system factors
    3. Wait for the patient to notice the error before acting
    4. Suppress the event to avoid reputational harm

    Explanation

    A just-culture approach encourages reporting and focuses on identifying system contributors rather than blame alone. This supports learning and prevention of future errors.

  174. Question 174Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is evaluating a prescription for a medication with a narrow therapeutic index. Which monitoring approach is most appropriate?

    1. Relying solely on the patient's report of side effects
    2. Therapeutic drug monitoring with attention to timing of levels Correct answer.
    3. No monitoring is needed if the patient feels well
    4. Monitoring only at the start of therapy

    Explanation

    Narrow therapeutic index drugs require therapeutic drug monitoring, with correct sampling timing relative to doses to interpret levels accurately. Symptoms alone are insufficient to guide dosing.

  175. Question 175Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following best describes the pharmacist's responsibility when dispensing a medication with a newly issued safety communication from the manufacturer?

    1. Delay dispensing until the communication is rescinded
    2. Ignore the communication unless the patient asks about it
    3. Review the communication and incorporate relevant safety information into practice Correct answer.
    4. Forward the communication only to the prescriber

    Explanation

    Safety communications convey important new risk information that pharmacists must review and integrate into dispensing, counseling, and monitoring. Ignoring or deferring action can expose patients to preventable harm.

  176. Question 176Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is verifying a prescription for a patient with a documented penicillin allergy who is prescribed amoxicillin. What is the most appropriate action?

    1. Dispense the medication because the allergy is not severe.
    2. Contact the prescriber to discuss an alternative antibiotic. Correct answer.
    3. Ask the patient to sign a waiver before dispensing.
    4. Dispense the medication with a warning label about allergy.

    Explanation

    A documented penicillin allergy is a contraindication to amoxicillin because both share the beta-lactam structure and cross-reactivity is possible. The pharmacist must contact the prescriber to recommend a non-beta-lactam alternative.

  177. Question 177Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a required element of a prescription for a Schedule II controlled substance?

    1. The pharmacy's NPI number.
    2. The prescriber's DEA registration number. Correct answer.
    3. The patient's insurance policy number.
    4. The patient's social security number.

    Explanation

    Federal law requires that a prescription for a Schedule II controlled substance include the prescriber's DEA registration number, which authorizes the prescriber to handle controlled substances.

  178. Question 178Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is preparing to dispense a medication that requires reconstitution before oral administration. Which practice is most appropriate?

    1. Reconstitute only when the patient presents to pick up the medication.
    2. Reconstitute and store at room temperature for the remainder of the expiration date.
    3. Reconstitute with the diluent specified in the product labeling and assign a beyond-use date. Correct answer.
    4. Reconstitute with sterile water for injection regardless of the label.

    Explanation

    Reconstitution must follow the manufacturer's labeling for the correct diluent, concentration, and storage, and the resulting product must be assigned a beyond-use date based on the labeled stability.

  179. Question 179Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following best describes the purpose of a pharmacist's final verification before dispensing a prescription?

    1. To verify that the prescriber's office is open.
    2. To confirm that the patient has insurance coverage for the medication.
    3. To ensure the prescription is accurate, legal, and clinically appropriate. Correct answer.
    4. To determine the retail price of the medication.

    Explanation

    Final verification is a safety check to ensure the prescription is valid, the drug and dose are appropriate, and all legal requirements are met before the medication reaches the patient.

  180. Question 180Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A patient requests a refill of a prescription that has no refills remaining. What is the most appropriate action for the pharmacist?

    1. Refuse the refill and instruct the patient to call the prescriber.
    2. Contact the prescriber to request authorization for additional refills. Correct answer.
    3. Dispense a partial fill and document the exception.
    4. Dispense the refill and note that authorization is pending.

    Explanation

    When no refills remain, the pharmacist must obtain new authorization from the prescriber before dispensing additional medication, except in specific emergency situations defined by law.

  181. Question 181Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a key responsibility of a pharmacist when conducting a medication therapy management (MTM) session?

    1. Diagnosing new medical conditions and prescribing treatment.
    2. Dispensing medications without a prescription.
    3. Adjusting insulin doses without consulting the prescriber.
    4. Performing a comprehensive medication review and developing a plan to resolve medication-related problems. Correct answer.

    Explanation

    MTM involves a comprehensive review of the patient's medications to identify and resolve medication-related problems, often resulting in a medication action plan and recommendations to the prescriber.

  182. Question 182Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is asked to dispense a medication that is subject to a Risk Evaluation and Mitigation Strategy (REMS) with Elements to Assure Safe Use (ETASU). Which action is required?

    1. Dispense the medication only if the patient signs a general consent form.
    2. Dispense the medication with a standard patient information leaflet.
    3. Dispense the medication after verifying the prescriber is enrolled and the patient meets the ETASU requirements. Correct answer.
    4. Dispense the medication without additional requirements because REMS applies only to prescribers.

    Explanation

    For REMS with ETASU, the pharmacy and prescriber must be certified, and the pharmacist must verify that the patient meets the ETASU requirements before dispensing.

  183. Question 183Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is the most appropriate way for a pharmacist to prevent medication errors related to look-alike/sound-alike (LASA) drug names?

    1. Dispense LASA medications without auxiliary labels.
    2. Rely on memory to distinguish LASA medications.
    3. Store LASA medications next to each other for easy comparison.
    4. Use tall man lettering and separate storage for LASA medications. Correct answer.

    Explanation

    Tall man lettering (e.g., predniSONE vs prednisoLONE) and physical separation of LASA products help reduce selection errors by making differences more visible.

  184. Question 184Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is reviewing a prescription for warfarin and notices the patient is also taking a new prescription for trimethoprim-sulfamethoxazole. What is the most appropriate action?

    1. Dispense both medications and advise the patient to monitor for bruising.
    2. Refuse to dispense the antibiotic and instruct the patient to see another pharmacy.
    3. Dispense the antibiotics and tell the patient to stop warfarin temporarily.
    4. Contact the prescriber to discuss the interaction and recommend an alternative antibiotic or increased INR monitoring. Correct answer.

    Explanation

    Trimethoprim-sulfamethoxazole can potentiate warfarin's anticoagulant effect and increase bleeding risk. The pharmacist should contact the prescriber to consider an alternative or ensure close INR monitoring.

  185. Question 185Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a required component of a medication error report in a pharmacy?

    1. The prescriber's office phone number.
    2. The pharmacy's daily sales total.
    3. A description of the error, the medication involved, and the outcome. Correct answer.
    4. The name of the patient's insurance company.

    Explanation

    Medication error reports should capture what happened, which medication was involved, and the effect on the patient to support analysis and prevention.

  186. Question 186Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is asked to compound a sterile preparation that will be administered intravenously. Which practice is most appropriate?

    1. Compound in a designated area with a laminar airflow hood that has not been certified.
    2. Compound in a cleanroom with an ISO Class 5 environment and follow USP <797> standards. Correct answer.
    3. Compound at the dispensing counter using aseptic technique.
    4. Compound without a prescription because it is a sterile product.

    Explanation

    Sterile compounding must occur in an environment that meets USP <797> requirements, including an ISO Class 5 primary engineering control within a classified cleanroom.

  187. Question 187Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A patient with asthma is prescribed a metered-dose inhaler. Which counseling point is most important for the pharmacist to include?

    1. Shake the inhaler and coordinate actuation with inhalation. Correct answer.
    2. Store the inhaler in the refrigerator.
    3. Use the inhaler only when symptoms are severe.
    4. Rinse the mouth after using a bronchodilator inhaler.

    Explanation

    Proper technique for a metered-dose inhaler includes shaking the device and coordinating actuation with a slow, deep breath to ensure the medication reaches the lungs.

  188. Question 188Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following best describes the pharmacist's role in antimicrobial stewardship?

    1. Promoting appropriate antibiotic selection, dose, and duration to optimize outcomes and reduce resistance. Correct answer.
    2. Dispensing antibiotics without questioning the prescriber.
    3. Encouraging patients to stop antibiotics when they feel better.
    4. Limiting antibiotic use to hospital settings only.

    Explanation

    Antimicrobial stewardship involves optimizing antimicrobial use through appropriate selection, dosing, and duration, which improves outcomes and minimizes resistance.

  189. Question 189Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist receives a prescription for a controlled substance that appears to be altered. What is the most appropriate action?

    1. Refuse to dispense and report the patient to law enforcement immediately.
    2. Ask the patient to obtain a new prescription from a different prescriber.
    3. Contact the prescriber to verify the prescription and do not dispense until confirmed. Correct answer.
    4. Dispense the prescription and document the alteration.

    Explanation

    When a controlled substance prescription appears altered, the pharmacist must verify its authenticity with the prescriber before dispensing to prevent fraud and ensure patient safety.

  190. Question 190Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is an example of a high-alert medication that requires independent double-check before administration?

    1. Loratadine 10 mg tablets.
    2. Acetaminophen 500 mg tablets.
    3. Intravenous heparin infusion. Correct answer.
    4. Multivitamin with minerals.

    Explanation

    Intravenous heparin is a high-alert medication because of its narrow therapeutic index and risk of serious bleeding; independent double-checks are recommended to prevent dosing errors.

  191. Question 191Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is performing a medication reconciliation for a patient admitted to the hospital. Which action is most important?

    1. Obtain a complete list of the patient's medications, including over-the-counter products and supplements. Correct answer.
    2. Focus only on prescription medications.
    3. Prescribe new medications to replace home medications.
    4. Discontinue all home medications upon admission.

    Explanation

    Medication reconciliation requires a comprehensive list of all medications the patient is taking, including prescription, over-the-counter, and herbal products, to avoid discrepancies.

  192. Question 192Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a critical step in preventing cross-contamination during nonsterile compounding?

    1. Compounding multiple prescriptions simultaneously without separation.
    2. Using the same equipment for all ingredients without cleaning between uses.
    3. Cleaning and sanitizing equipment and surfaces between different compounding operations. Correct answer.
    4. Storing all ingredients together in one container.

    Explanation

    Cleaning and sanitizing equipment and surfaces between compounding operations prevents cross-contamination between different ingredients and preparations.

  193. Question 193Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A patient with a history of angioedema while taking an ACE inhibitor is prescribed sacubitril/valsartan. What is the most appropriate action for the pharmacist?

    1. Contact the prescriber because sacubitril/valsartan is contraindicated in patients with a history of ACE inhibitor–associated angioedema. Correct answer.
    2. Dispense the medication and advise the patient to monitor for swelling.
    3. Dispense the medication only if the patient has no current symptoms.
    4. Dispense the medication with a warning about angioedema.

    Explanation

    Sacubitril/valsartan is contraindicated in patients with a history of angioedema related to ACE inhibitors due to the risk of recurrence. The prescriber must be contacted for an alternative.

  194. Question 194Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following is a required practice for a pharmacy that dispenses a drug with a boxed warning about hepatotoxicity?

    1. Provide the patient with a medication guide if required by the manufacturer. Correct answer.
    2. Store the medication in a separate refrigerator.
    3. Withhold the medication guide to avoid alarming the patient.
    4. Dispense the medication without any counseling.

    Explanation

    When a medication guide is required as part of the labeling for a drug with a boxed warning, the pharmacy must provide it to the patient with each dispensing.

  195. Question 195Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is asked to dispense a medication that is not FDA-approved but is available under an expanded access program. Which action is most appropriate?

    1. Dispense the medication only if the patient pays cash.
    2. Refuse to dispense because investigational drugs cannot be dispensed by pharmacies.
    3. Verify that the prescriber has obtained the necessary approvals and document the dispensing. Correct answer.
    4. Dispense the medication without documentation because it is investigational.

    Explanation

    Investigational drugs under expanded access require proper authorization and documentation; the pharmacist must verify approvals and maintain records.

  196. Question 196Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    Which of the following best describes the pharmacist's responsibility when a patient reports a suspected adverse drug reaction?

    1. Assess the reaction, provide guidance, and report to the appropriate authority if serious. Correct answer.
    2. Ignore the report because adverse reactions are the prescriber's responsibility.
    3. Advise the patient to stop the medication immediately without consulting the prescriber.
    4. Report the reaction only if the patient requests it.

    Explanation

    Pharmacists should assess suspected adverse drug reactions, provide appropriate guidance, and report serious reactions to programs such as MedWatch.

  197. Question 197Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is reviewing a prescription for methotrexate 2.5 mg tablets with directions to take 7.5 mg daily. What is the most appropriate action?

    1. Dispense with a warning label about daily use.
    2. Contact the prescriber because daily methotrexate dosing is potentially fatal; the regimen may be intended as weekly. Correct answer.
    3. Reduce the dose to 2.5 mg daily without consulting the prescriber.
    4. Dispense as written because the prescriber's intent is clear.

    Explanation

    Methotrexate for non-oncologic indications is typically dosed weekly; daily dosing can cause severe toxicity. The pharmacist must clarify with the prescriber before dispensing.

  198. Question 198Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is evaluating a prescription for a patient with severe renal impairment (CrCl < 30 mL/min) for a medication that is renally eliminated. Which action is most appropriate?

    1. Refuse to dispense the medication.
    2. Dispense the medication with a warning to drink plenty of water.
    3. Recommend a dose adjustment based on the patient's renal function and the product labeling. Correct answer.
    4. Dispense the standard dose because renal impairment does not affect dosing.

    Explanation

    For renally eliminated drugs, doses often require adjustment in renal impairment to avoid toxicity; the pharmacist should recommend an appropriate dose based on labeling and clinical guidelines.

  199. Question 199Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is verifying a prescription for a patient with a history of QT prolongation who is prescribed ondansetron and haloperidol. What is the most appropriate action?

    1. Dispense the medications with a warning to avoid grapefruit juice.
    2. Reduce the dose of ondansetron without consulting the prescriber.
    3. Contact the prescriber to discuss the additive QT-prolonging effect and consider alternatives. Correct answer.
    4. Dispense both medications because the interaction is minor.

    Explanation

    Both ondansetron and haloperidol can prolong the QT interval; their combined use increases the risk of serious arrhythmias, especially in a patient with a history of QT prolongation. The prescriber should be consulted.

  200. Question 200Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

    A pharmacist is preparing to dispense a medication that requires a specialized delivery device. Which action best ensures patient safety?

    1. Assume the patient knows how to use the device from prior experience.
    2. Provide device training and verify the patient's technique before dispensing. Correct answer.
    3. Provide only written instructions and no demonstration.
    4. Dispense the device without instructions because the prescriber will train the patient.

    Explanation

    For medications requiring specialized devices, the pharmacist should provide training and verify technique to ensure correct use and avoid errors.

CPJE flashcards

32 cards. Read the term and the definition here. The deck at the top of this page is optional.

CE requirement for pharmacists
California pharmacists must complete 30 hours of continuing education every two years, including one hour in pharmacy law and one hour in patient safety/medication errors.
Schedule II prescription validity
A Schedule II prescription in California is valid for six months from the date written and cannot be refilled; emergency oral prescriptions require written follow-up within seven days.
Prescription record retention
California pharmacies must retain prescription records for at least three years from the date of dispensing; records must be readily retrievable for inspection.
Patient counseling requirement
Pharmacists must offer counseling on new prescriptions and on refills with changed strength or directions; the patient may decline counseling.
Pharmacist immunization authority
California pharmacists may administer immunizations to individuals aged three and older under a protocol with trained personnel and appropriate documentation.
DUR components
Drug utilization review includes screening for therapeutic duplication, drug-disease contraindications, drug-drug interactions, incorrect dosage, and allergy cross-sensitivities.
Prescription label elements
Labels must include pharmacy name and address, prescription number, date, patient name, prescriber, directions, drug name and strength, quantity, expiration date, and refills.
Board of Pharmacy disciplinary actions
The California Board of Pharmacy may revoke, suspend, or place a license on probation, and may impose fines for violations of pharmacy law.
Oral Schedule II emergency
In an emergency, a pharmacist may dispense a Schedule II drug on an oral prescription limited to a five-day supply, with a written prescription due within seven days.
Pharmacist-in-charge duties
The PIC ensures legal compliance, maintains records, supervises staff, and implements quality assurance and continuous quality improvement programs.
Medication error prevention
Use tall man lettering for look-alike/sound-alike drugs and verify patient identity with two identifiers before dispensing to reduce medication errors.
USP <795> scope
USP <795> sets standards for nonsterile compounding, including personnel training, facility requirements, and assignment of beyond-use dates based on stability.
USP <797> scope
USP <797> governs sterile compounding, requiring ISO Class 5 environments, proper garbing, disinfection, and validated beyond-use dates.
High-alert medications
High-alert medications such as insulin, heparin, chemotherapy, and opioids require independent double-checks and standardized concentrations to prevent harm.
Medication history components
A complete medication history includes prescription drugs, over-the-counter products, supplements, allergies, and adherence patterns to identify drug-related problems.
Dispensing accuracy check
Verify the prescription against the original order for drug, strength, dosage form, quantity, and directions; use barcode scanning when available.
Adverse event reporting
Serious adverse drug events should be reported to FDA MedWatch and documented in the patient record and internal reporting system.
Sterile compounding immediate-use
Immediate-use sterile preparations must be prepared in an ISO Class 5 environment and administered within one hour unless otherwise specified.
Quality assurance program
Pharmacies must maintain a quality assurance program that tracks medication errors, identifies causes, and implements system improvements.
Patient assessment steps
Assess the patient by obtaining medication and allergy history, reviewing labs, and identifying adherence, adverse effects, and interactions.
Beyond-use date assignment
Beyond-use dates for compounded preparations are based on stability data, storage conditions, and container type, following USP guidelines.
Independent double-check
A second pharmacist or technician verifies the drug, dose, and calculations independently before dispensing high-alert medications.
Tall man lettering
Tall man lettering uses uppercase letters to highlight differences in look-alike/sound-alike drug names, reducing selection errors.
Two patient identifiers
Verify patient identity using two identifiers, such as name and date of birth, before dispensing or administering medications.
Medication reconciliation
The process of comparing a patient's medication orders to all medications the patient has been taking to avoid omissions, duplications, or errors.
Sterile garbing requirements
Personnel must wear appropriate garb including gloves, gown, mask, and hair cover, and must follow hand hygiene and disinfection procedures.
Compounding personnel training
Compounding personnel must be trained and evaluated for competency in techniques, hygiene, and equipment use before compounding.
Prescription verification
The pharmacist verifies the prescription for legality, authenticity, and appropriateness before dispensing, including dose and directions.
Medication error reporting system
An internal system for reporting and analyzing medication errors to identify trends and implement preventive strategies.
Patient counseling documentation
Document that counseling was offered and whether the patient accepted or declined it, including any written information provided.
Refill authorization
Pharmacists may refill prescriptions only if authorized by the prescriber and within the number of refills and expiration date specified.
Prescriber verification
Pharmacists must verify the prescriber's identity and authority, especially for controlled substances, to prevent fraud.

CPJE study guide

California Pharmacy Law and Jurisprudence: Structure, Scope, and Enforcement

California pharmacy law is tested as a system, not a list of isolated numbers. Anchor yourself in three layers: the Business and Professions Code (B&P), which contains the Pharmacy Law; the California Code of Regulations, Title 16, which supplies the Board of Pharmacy's implementing rules; and federal law (CSA, FDCA), which sets a floor California may exceed. Know the Board's composition and authority, the licensure categories (pharmacist, intern, pharmacy technician, designated representative-required entities), and the self-reporting duty: pharmacists must report to the Board within 30 days any change of address, and arrests or convictions (including nolo contendere pleas) that could affect licensure, generally within 30 days. The Board may discipline for unprofessional conduct, and the Uniform Controlled Substances Act (Health & Safety Code) governs C-II through C-V handling, including the CURES prescription drug monitoring database, which requires consultation before the first dispensing of a Schedule II-IV opioid and at least every six months thereafter while the course continues, plus mandatory querying in defined red-flag situations. Traps: distinguishing Board rule from statute; confusing reporting deadlines (address change vs. arrest reporting); assuming CURES applies to all controlled substances (it targets opioids, with benzodiazepines and other schedules added under specified conditions); and mixing California's stricter refill/transmission rules with DEA defaults. Also know the pedigree/e-pedigree concepts for the drug supply chain, the prohibition on dispensing by unlicensed persons, and the requirement that a pharmacist be on premises for pharmacy operation and patient counseling.

Rule of thumb: when two deadlines conflict, California's specific statute controls; when a federal minimum exists, California may be stricter but never looser.

Worked example: A pharmacist is arrested for DUI but not convicted. She must still report the arrest to the Board within 30 days - the duty is triggered by the arrest, not the disposition.

Pharmacist Practice Standards: Patient Care, Dispensing, Compounding, and Medication Safety

This domain tests whether you can run a compliant, safe workflow. Start with the prescription record: valid elements, prescriber identification, and the pharmacist's corresponding responsibility to resolve legibility, dose, and therapeutic problems before dispensing. Patient counseling is mandatory (in person or by phone) unless the patient declines; document refusals. Know substitution rules - generic substitution requires patient consent, and interchangeable biological products follow California's notification framework (prescriber notification and patient communication within defined timelines).

Compounding splits into traditional (patient-specific) and sterile compounding under USP <797>/<800> expectations: segregated compounding areas, environmental monitoring, beyond-use dating grounded in risk level, and hazardous-drug handling with closed-system transfer devices and personal protective equipment. Traps: applying non-sterile BUDs to sterile preparations; forgetting that a prescription is required for patient-specific compounds; and ignoring the requirement to report medication errors and adverse events through the Board's reporting system when they cause serious harm.

Medication safety questions reward systems thinking: high-alert medications, look-alike/sound-alike names, independent double checks, tall-man lettering, and error-prone abbreviations (trailing zeros, U for units). Know REM/risk evaluation obligations for drugs with restricted distribution and the pharmacist's role in immunization (protocol, training, and reporting to CAIR).

Rule of thumb: if a question offers "clarify with the prescriber" versus "dispense and note," choose clarification whenever the order is ambiguous or potentially harmful.

Worked example: A prescription reads "Warfarin 5 mg, take 5 mg daily, 5.0 mg tablets." The trailing zero and duplication create error risk; the pharmacist should clarify the intended dose and quantity rather than infer.

Document every intervention.

CPJE cheat sheet

Quick reference

California Pharmacy Law and Jurisprudence

  • Pharmacist license renewal: every 2 years; 30 hours of CE required, including 1 hour on pharmacy law and 1 hour on patient safety/medication errors.

  • Prescription records: must be retained for at least 3 years from the date of dispensing; electronic records acceptable if readily retrievable.

  • Controlled substances: Schedule II prescriptions require a handwritten or electronically transmitted prescription; no refills; valid for 6 months from date written.

  • Oral prescriptions for Schedule II: allowed only in emergency situations with written follow-up within 7 days; limited to a 5-day supply.

  • Pharmacist may administer immunizations to persons aged 3 and older per current California law (varies by vaccine and protocol).

  • California Pharmacists Association (CPhA) and Board of Pharmacy: the Board licenses pharmacists, interns, technicians, and pharmacies; disciplinary actions include revocation, suspension, probation, and fines.

  • Patient counseling: pharmacist must offer counseling on new prescriptions and when a prescription is refilled with a different strength or directions; may be declined by patient.

  • Drug utilization review (DUR): pharmacist must review for therapeutic duplication, drug-disease contraindications, drug-drug interactions, incorrect dosage, and allergy contraindications.

  • Prescription label requirements: pharmacy name, address, prescription number, date, patient name, prescriber name, directions for use, drug name/strength, quantity, expiration date, and number of refills.

Quick reference

Pharmacist Practice Standards

  • Medication error prevention: use tall man lettering for look-alike/sound-alike drugs; verify patient identity using two identifiers before dispensing.

  • Compounding: follow USP <795> for nonsterile and <797> for sterile compounding; maintain beyond-use dates based on stability and storage conditions.

  • High-alert medications: independent double-check for insulin, heparin, chemotherapy, and opioids; use standardized concentrations and infusion pumps.

  • Patient assessment: obtain medication history, allergy history, and relevant labs; identify drug-related problems (adherence, adverse effects, interactions).

  • Dispensing accuracy: verify prescription against original order; check drug, strength, dosage form, quantity, and directions; use barcode scanning when available.

  • Adverse drug event reporting: report serious adverse events to FDA MedWatch and to the pharmacy's internal reporting system; document in patient record.

  • Sterile compounding: maintain ISO Class 5 environment for immediate use; follow hand hygiene, garbing, and disinfection procedures; assign beyond-use dates per USP <797>.

  • Pharmacist-in-charge responsibilities: ensure compliance with laws, maintain records, supervise personnel, and implement quality assurance programs.

CPJE key terms

Board of Pharmacy

The California state agency that licenses pharmacists and pharmacies, adopts regulations, and enforces the Pharmacy Law through inspections, investigations, and disciplinary action.

Related: Pharmacy Law, Citation, Probationary License
Pharmacy Law

The body of California statutes and Board regulations governing pharmacy practice, including the Business and Professions Code pharmacy provisions and Title 16 of the California Code of Regulations.

Related: Board of Pharmacy, Self-Reporting Requirement
Pharmacist-in-Charge

The licensed pharmacist designated by a pharmacy to be responsible for its overall operation, including compliance with law, recordkeeping, security, and supervision of personnel.

Related: Pharmacy Technician Ratio, Continuous Quality Improvement Program
Pharmacy Technician Ratio

The limit on how many certified or licensed pharmacy technicians one pharmacist may supervise at a given time, which varies with the practice setting and the technician's licensure status.

Related: Pharmacist-in-Charge, Pharmacy Technician
Pharmacy Technician

A person registered or licensed by the Board to assist a pharmacist with non-discretionary tasks such as data entry, counting, labeling, and stock management under pharmacist supervision.

Related: Pharmacy Technician Ratio, Pharmacist-in-Charge
Intern Pharmacist

A pharmacy student or graduate registered with the Board who gains supervised practice hours toward licensure and may perform pharmacist duties only under direct pharmacist supervision.

Related: Pharmacist License, Pharmacy Technician
Pharmacist License

The credential issued by the Board authorizing a person to practice pharmacy in California after meeting education, examination, and internship requirements, renewable on a set cycle.

Related: Intern Pharmacist, Continuing Education Requirement
Continuing Education Requirement

The minimum number of approved education hours a licensee must complete during each renewal period, including any mandated topic hours such as law and patient safety.

Related: Pharmacist License, Self-Reporting Requirement
Self-Reporting Requirement

A licensee's legal duty to notify the Board within a specified time after certain events, such as arrest, conviction, or disciplinary action by another licensing authority.

Related: Board of Pharmacy, Pharmacy Law
Citation

A formal notice of an alleged violation issued by the Board that may carry fines or orders of abatement and can be contested through an administrative appeal process.

Related: Board of Pharmacy, Probationary License
Probationary License

A restricted license that allows practice under specified conditions and monitoring imposed by the Board as a disciplinary outcome instead of outright revocation.

Related: Citation, Board of Pharmacy
Prescription Drug Label Requirements

The mandated information a pharmacy must print on a dispensed prescription container, including patient name, drug name and strength, directions, quantity, prescriber, pharmacy, and required cautions.

Related: Prescription Record Retention, Patient Counseling
Prescription Record Retention

The minimum period a pharmacy must keep prescription and dispensing records on file and readily retrievable for inspection by the Board and other authorized agencies.

Related: Prescription Drug Label Requirements, Pharmacist-in-Charge
Patient Counseling

A pharmacist's required offer of verbal consultation to a patient or caregiver about a new or changed prescription, covering proper use, storage, and significant risks.

Related: Prescription Drug Label Requirements, Medication Therapy Management
Refill Authorization

The prescriber's permission allowing a pharmacy to dispense additional supplies of a prescription, which must be documented and limited by the original order.

Related: Prescription Record Retention, Prescription Transfer
Prescription Transfer

The process of moving an active prescription from one pharmacy to another, requiring pharmacist-to-pharmacist communication and documentation of the transfer details.

Related: Refill Authorization, Prescription Record Retention
Drug Enforcement Administration Registration

The federal registration required for a pharmacy or practitioner to handle controlled substances, which must be current before dispensing or ordering such drugs.

Related: Controlled Substance Schedule, CURES
Controlled Substance Schedule

The federal and state classification of drugs by abuse potential and accepted medical use, which determines prescribing, dispensing, refill, and recordkeeping rules.

Related: Drug Enforcement Administration Registration, CURES
CURES

The California prescription drug monitoring database that pharmacists and prescribers query to review a patient's history of controlled substance dispensing.

Related: Controlled Substance Schedule, Drug Enforcement Administration Registration
Clozapine Monitoring

A risk-management program requiring periodic white blood cell monitoring for patients taking clozapine, with dispensing restricted until results are confirmed and documented.

Related: Risk Evaluation and Mitigation Strategy, Prescription Record Retention
Risk Evaluation and Mitigation Strategy

A FDA-required safety program for certain drugs that may restrict dispensing, require patient or prescriber certification, or mandate specific counseling and monitoring.

Related: Clozapine Monitoring, Patient Counseling
Medication Error

Any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of a health care professional or patient.

Related: Continuous Quality Improvement Program, Medication Safety
Continuous Quality Improvement Program

A pharmacy's required systematic process for detecting, documenting, analyzing, and preventing medication errors and improving dispensing accuracy over time.

Related: Medication Error, Medication Safety
Medication Safety

The practices and systems designed to prevent medication errors and adverse drug events, including verification, labeling, counseling, and error reporting.

Related: Medication Error, Continuous Quality Improvement Program
Medication Reconciliation

The process of comparing a patient's current medication list with new orders to identify discrepancies, omissions, duplications, or interactions at transitions of care.

Related: Medication Therapy Management, Medication Safety
Medication Therapy Management

A pharmacist-delivered service that reviews a patient's medications to optimize outcomes, improve adherence, and reduce adverse events, often provided under a collaborative agreement.

Related: Collaborative Practice Agreement, Medication Reconciliation
Collaborative Practice Agreement

A written agreement between a pharmacist and prescriber authorizing the pharmacist to initiate, adjust, or discontinue drug therapy under defined conditions and protocols.

Related: Medication Therapy Management, Prescriptive Authority
Prescriptive Authority

The legal ability to authorize drug therapy, which pharmacists may exercise only within specific statutory exceptions or under a valid collaborative or protocol arrangement.

Related: Collaborative Practice Agreement, Medication Therapy Management
Compounding

The preparation, mixing, or altering of a drug product to meet a specific patient's needs, subject to standards for equipment, ingredients, personnel training, and quality assurance.

Related: Sterile Compounding, United States Pharmacopeia Standards
Sterile Compounding

Preparation of sterile products such as injectable or ophthalmic dosage forms, requiring controlled environments, validated processes, and specialized training and testing.

Related: Compounding, United States Pharmacopeia Standards
United States Pharmacopeia Standards

Nationally recognized compounding and quality standards, including general chapters on nonsterile and sterile preparation, that California pharmacies must follow.

Related: Compounding, Sterile Compounding
Beyond-Use Date

The date after which a dispensed or compounded preparation should not be used, determined from stability data and the conditions under which it is stored.

Related: Compounding, Sterile Compounding
Drug Utilization Review

A structured review of a patient's drug therapy to screen for interactions, duplications, dosing problems, and appropriateness before or after dispensing.

Related: Medication Reconciliation, Medication Safety
Adverse Drug Event

An injury or harm resulting from a medication, including adverse reactions, errors, and overdoses, which should be identified and managed to protect the patient.

Related: Medication Error, Medication Safety
Pharmacist Verification

The final check by a pharmacist confirming that a prepared prescription matches the prescriber's order in drug, strength, quantity, labeling, and directions before dispensing.

Related: Medication Error, Continuous Quality Improvement Program
High-Alert Medication

A drug with a heightened risk of significant harm when used in error, requiring extra safeguards such as independent double checks and distinctive labeling.

Related: Medication Safety, Pharmacist Verification
Look-Alike Sound-Alike Drug

Medications whose names or packaging are easily confused, a common source of dispensing errors that warrants special storage, labeling, and verification precautions.

Related: Medication Error, High-Alert Medication
Pharmacy Security

The measures a pharmacy must maintain to prevent theft, diversion, or unauthorized access, including locked storage of controlled substances and limited key access.

Related: Controlled Substance Schedule, Pharmacist-in-Charge

CPJE study plan

8 weeks · About 6 hours per week

Week 1

California pharmacy law and jurisprudence

  • Outline the structure and key provisions of the California Pharmacy Law (Business and Professions Code and Board of Pharmacy regulations).

  • Define the roles and responsibilities of the California State Board of Pharmacy, including licensing, enforcement, and disciplinary actions.

  • List the requirements for pharmacist licensure, renewal, and continuing education in California.

  • Describe the requirements for pharmacy technician registration and the ratio of technicians to pharmacists.

Your checkpoint

Create a one-page summary sheet of California pharmacy licensure and Board structure.

Week 2

California pharmacy law and jurisprudence

  • Explain the legal requirements for prescription dispensing, including labeling, recordkeeping, and patient counseling.

  • Differentiate between Schedule II-V controlled substances and describe the corresponding handling, storage, and reporting requirements under California law.

  • Identify the laws governing prescription transfers, refills, and emergency dispensing.

  • Describe the requirements for pharmacy security, including alarm systems and access control.

Your checkpoint

Draft a checklist for compliant dispensing of a controlled substance prescription in California.

Week 3

California pharmacy law and jurisprudence

  • Summarize California laws on compounding, including sterile and non-sterile compounding standards.

  • Explain the requirements for automated dispensing systems and telepharmacy in California.

  • Describe the legal obligations for reporting medication errors and adverse events.

  • Outline the laws related to pharmacy ownership, including restrictions on physician ownership and the role of the designated representative.

Your checkpoint

Write a 1-page comparison of California compounding regulations for sterile vs. non-sterile preparations.

Week 4

California pharmacy law and jurisprudence

  • Review and apply California law to case scenarios involving dispensing errors, patient privacy, and controlled substances.

  • Explain the legal framework for collaborative practice agreements and protocol-based prescribing.

  • Describe the requirements for pharmacy closures and transfer of prescription records.

  • Identify the penalties for violations of California pharmacy law, including fines and license actions.

Your checkpoint

Complete 20 practice questions on California pharmacy law with a score of at least 80%.

Week 5

Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

  • Outline the pharmacist patient care process, including assessment, diagnosis, and development of a care plan.

  • Describe the key elements of medication therapy management (MTM) and comprehensive medication reviews.

  • Explain the principles of pharmacokinetics and pharmacodynamics as they apply to dosing and monitoring.

  • Identify common drug interactions and adverse drug reactions, and describe strategies for prevention and management.

Your checkpoint

Create a patient case presentation for a patient with multiple chronic conditions, including a medication action plan.

Week 6

Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

  • Describe the steps in the dispensing process, including prescription verification, interpretation, and product selection.

  • Explain the requirements for patient counseling and medication education.

  • Outline the standards for sterile and non-sterile compounding, including facility, equipment, and personnel requirements.

  • Identify strategies to prevent medication errors and improve medication safety in pharmacy practice.

Your checkpoint

Develop a standard operating procedure for dispensing a high-alert medication with safety checks.

Week 7

Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

  • Explain the pharmacist's role in immunizations, including vaccine storage, administration, and documentation.

  • Describe the management of patients with special populations (e.g., pediatrics, geriatrics, pregnancy) and corresponding dosing adjustments.

  • Interpret common laboratory values and apply them to medication monitoring.

  • Outline the process for reporting adverse drug events to the FDA and other agencies.

Your checkpoint

Prepare a 10-minute oral presentation on medication safety in special populations.

Week 8

California pharmacy law and jurisprudence & Pharmacist practice standards (patient care, dispensing, compounding, and medication safety)

  • Integrate California law and practice standards by solving case-based scenarios.

  • Review weak areas identified from previous practice questions and targeted study.

  • Complete a full-length practice exam under timed conditions.

  • Analyze practice exam results to identify remaining knowledge gaps and create a final review plan.

Your checkpoint

Score at least 75% on a comprehensive 100-question practice exam covering both domains.

Milestones

Week 4: Pass a 30-question California pharmacy law quiz with a score of 80% or higher.

Week 6: Successfully complete a medication safety case analysis and present findings.

Week 8: Achieve a score of 75% or higher on a full-length practice exam covering both domains.

CPJE exam day

Your checklist

Government-issued photo ID

Bring the exact form of ID the testing vendor requires (typically a current driver's license or passport). Confirm with the provider which IDs are accepted and whether the name must match your registration exactly.

Admission/authorization confirmation

Have your scheduling confirmation or authorization-to-test notice available. The exact document required varies, so confirm with the provider what to print or display.

Know your test center location and route

Look up the address, parking, and transit options ahead of time and plan to arrive early. Traffic and security screening can consume extra time.

Arrival timing

Arrive before your scheduled start; late arrivals may be refused entry. Confirm with the provider the specific arrival cutoff for your appointment.

Permitted items only

Bring only what the vendor allows into the testing room. Personal items are usually stored in a locker. Confirm with the provider the current list of prohibited items (phones, watches, notes, etc.).

No outside reference materials

Do not bring or attempt to use notes, textbooks, or study aids. The exam is closed-book.

Calculator policy

Determine in advance whether a calculator is provided on-screen or whether any physical calculator is permitted. Do not assume; confirm with the provider.

Scratch materials

Find out whether scratch paper or a marker board is supplied and whether you may bring your own. Confirm with the provider.

Break and timing expectations

Review how breaks work and whether the clock stops during breaks. Confirm with the provider so you can budget your time.

Rest and logistics the night before

Get normal sleep, eat beforehand, and hydrate. Plan for a potentially long sitting and know your scheduled report time.

Test-day contact information

Save the vendor's phone number in case of an emergency or scheduling problem. Confirm with the provider where to call.

Read the candidate handbook

Review the official candidate handbook for conduct, scoring, and retake rules. This is the authoritative source; details below are general and should be verified.

Plan the day

Final 72 hours

Stop learning new material. Do focused review of high-yield topics and your own weak areas, take one or two timed practice sets, and confirm your test center logistics and ID requirements.

Final 72 hours

Protect sleep. Shift your schedule so you are alert at your appointment time, and avoid all-night cramming.

24 hours before

Do a light review only, then stop. Pack your ID and confirmation, lay out clothes, confirm the route and arrival time, and set two alarms.

24 hours before

Eat a normal dinner, avoid heavy alcohol, and get a full night's sleep. Re-read the vendor's prohibited-items list so nothing gets you turned away.

Morning of

Eat a real breakfast, hydrate moderately, arrive early, and leave your phone and other prohibited items secured as the vendor directs.

During the test

Read each question fully and watch for qualifiers like 'except' and 'best'. Answer every question; there is generally no penalty for guessing, but confirm the scoring rule with the provider.

During the test

Pace yourself against the number of questions and time allowed. Flag uncertain items, keep moving, and return to them if time permits.

During the test

Use breaks as allowed, but remember the clock may keep running. Confirm break rules with the provider before you start.

Rules to check

  • Bring only the ID and items the vendor permits; store everything else as directed. Confirm the current prohibited-items list with the provider.

  • Your name on the registration must match your ID. Resolve any mismatch before test day; confirm the provider's name-change policy.

  • Do not communicate with other candidates, use unauthorized materials, or attempt to record exam content. Suspected misconduct can lead to score cancellation.

  • Follow all proctor and test-center instructions, including any security screening and sign-in/sign-out procedures.

  • Breaks are typically available but may be counted against your time; confirm the exact break policy with the provider before you begin.

  • Scoring and pass/fail determination follow the provider's published rules; do not rely on a raw percentage you calculate yourself. Confirm with the provider.

  • If you need to reschedule or cancel, follow the provider's deadlines and fees; last-minute changes may forfeit your fee. Confirm with the provider.

  • If a technical or scheduling problem occurs on test day, notify the test-center staff immediately and document it; confirm the provider's reporting process.

CPJE FAQ

How many CPJE practice questions are available?

The practice set has 200 CPJE questions. Each one includes the choices, the correct answer, and an explanation, and the set is free to read with no signup.

How many CPJE flashcards are available?

The flashcard set has 32 CPJE cards. Each card shows the term and its definition.

Which topics does the CPJE study material cover?

The CPJE study material covers California Pharmacy Law and Jurisprudence: Structure, Scope, and Enforcement and Pharmacist Practice Standards: Patient Care, Dispensing, Compounding, and Medication Safety.

What format facts does the catalog list for the CPJE exam?

The catalog lists these item types: multiple choice for the CPJE exam.